Références sur la maladie à virus Ebola 2014-2018 liées à la Guinée, compilées par René Migliani

Professeur agrégé de l'Ecole du Val-de-Grâce
Médecin de santé publique et épidémiologiste
Membre de la Société de pathologie exotique
migliani.rene@gmail.com 


Télécharger le texte complet

  • Ade N, Réne A, Khalifa M, Babila KO, Monono ME, Tarcisse E. Coordination of the health policy dialogue process in Guinea: pre- and post-Ebola. BMC Health Serv Res 2016 Jul 18;16 Suppl 4:220. doi: 10.1186/s12913-016-1457-8.
  • International Ebola ResponseTeam, Agua-Agum J, Ariyarajah A, Aylward B, Bawo L, Bilivogui P, et al. Exposure patterns driving Ebola transmission in West Africa: a retrospective observational study. PLoSMed 2016;13(11): e1002170. doi:10.1371/journal.pmed.1002170.
  • Agusto FB, Teboh-Ewungkem MI, Gumel AB. Mathematical assessment of the effect of traditional beliefs and customs on the transmission dynamics of the 2014 Ebola outbreaks. BMC Med 2015; 13: 96.
  • Agut H. Le virus Ébola et sa détection. Séance dédiée : « Les financements innovants en matière de santé et l’épidémie à virus Ébola ». Bull Acad Natle Méd 2014;198:1493-1500
  • Ajelli M, Merler S, Fumanelli L, Pastore Y Piontti A, Dean NE, Longini IM Jr et al. Spatiotemporal dynamics of the Ebola epidemic in Guinea and implications for vaccination and disease elimination: a computational modeling analysis. BMC Med 2016 Sep 7;14(1):130. doi: 10.1186/s12916-016-0678-3
  • Ajisegiri WS, Chughtai AA, MacIntyre CR. A Risk Analysis Approach to prioritizing epidemics: Ebola virus disease in West Africa as a case study. Risk Anal 2017 Aug 15. doi: 10.1111/risa.12876
  • Akhtar A, Befkadu E, Basu P, Kumar P. Exposing the origins of the Ebola outbreak: urging for a shift in response from reactive to proactive. American Journal of Infectious Diseases and Microbiology 2014;2:1-18
  • Aletti M, Cambon A, Savini H, Billhot M, De Greslan T, Ficko C et al. Présentation clinique, aspects pronostiques et principes thérapeutiques de la maladie à virus Ebola : l’essentiel pour le clinicien. Médecine et Armées 2016;44:101-10.
  • Aletti M, Savini H, Ficko C, Bordes J, Cambon A, Billhot M et al. Ebola virus disease: Clinical presentation, prognosis and treatment. Rev Med Interne 2016 Oct 4. pii: S0248-8663(16)30471-4. doi: 10.1016/j.revmed.2016.07.006 [Epub ahead of print]
  • Alexander KA, Sanderson CE, Marathe M, Lewis BL, Rivers CM, Shaman J et al. What factors might have led to the emergence of Ebola in West Africa? PLoS Negl Trop Dis 2015 June 4;9(6):e0003652. doi:10.1371/journal.pntd.0003652.
  • Amalaman DM, Gakba TO, Ouattara S. Les enjeux socio-culturels de la lutte contre l’épidémie d’Ebola dans la Préfecture de Forécariah en Guinée Conakry. LONNIYA, Revue du Laboratoire des Sciences Sociales et des Organisations 2017;1:245-70
  • Amissah-Arthur MB, Poller B, Tunbridge A, Adebajo A. Musculoskeletal manifestations of Ebola virus. Rheumatology (Oxford) 2017 Apr 4. doi: 10.1093/rheumatology/kex082. [Epub ahead of print].
  • André AM, Lopez A, Perkins S, Lambert S, Chace L, Noudeke N et al. Frontline Field Epidemiology Training Programs as a Strategy to Improve Disease Surveillance and Response. Emerg Infect Dis 2017 Dec;23(13). doi: 10.3201/eid2313.170803.
  • Anoko J. La réparation de la malédiction générale suite à l’enterrement d’une femme enceinte avec le bébé dans le ventre. Une approche anthropologique pendant l’épidémie de la maladie à virus Ébola en Guinée. 2014. http://f.hypotheses.org/wp-content/blogs.dir/2225/files/2015/01/La-réparation-de-la-malédiction-générale-Julienne-Anoko-2014-12-22.pdf
  • Anoko J. Communication with rebellious communities during an outbreak of Ebola Virus Disease in Guinea: an anthropological approach. Réseau Ouest Africain SHS Ébola 2014 (en ligne). http://www.shsebola.hypotheses.org.
  • Anonyme. Bibliographie générale. Dossier : Épidémie d’Ébola : Quels enseignements ? adsp mars 2017;98:52-4.
  • Ansumana R, Keitell S, Roberts GM, Ntoumi F, Petersen E, Ippolito G et al. Impact of Infectious Disease Epidemics on Tuberculosis Diagnostic, Management and Prevention Services: Experiences and Lessons from the 2014-2015 Ebola Virus Disease Outbreak in West Africa. Int J Infect Dis 2016 Nov 3. pii: S1201-9712(16)31194-8. doi: 10.1016/j.ijid.2016.10.010.
  • Arima Y, Shimada T. Epidemiological situation of Ebola virus disease in West Africa. Uirusu 2015;65(1):47-54.
  • Attrait X, Miloche PO, Migliani R. Mission Ébola de l’UIISC7 en Guinée : retour d’expérience. Secours Santé Sapeurs-Pompiers Avril 2015;Hors-Série:23.
  • Augier A. Ébola : le rôle crucial des ONG médicales internationales. Dossier : Épidémie d’Ébola : Quels enseignements ? Tribunes. adsp mars 2017;98:47-9.
  • Awah PK, Boock AU, Kum KA. Ebola Virus Diseases in Africa: a commentary on its history, local and global context. Pan Afr Med J 2015;22 (S1):18. Published online 2015 Oct 11. doi: 10.11694/pamj.supp.2015.22.1.6652. eCollection 2015.
  • Ayouba A, Touré A, Butel C, Keita AK, Binetruy F, Sow MS et al. Development of a sensitive and specific serological assay based on the Luminex technology for the detection of antibodies to Zaire Ebola virus (EBOV). J Clin Microbiol 2016. doi:10.1128/JCM.01979-16.
  • Azuine RE, Ekejiuba SE, Singh GK, Azuine MA. Ebola Virus Disease Epidemic: What Can the World Learn and Not Learn from West Africa? International Journal of MCH and AIDS October 2015;3:1-6.
  • Backer JA, Wallinga J. Spatiotemporal Analysis of the 2014 Ebola Epidemic in West Africa. PLoS Comput Biol 2016 Dec 8;12(12):e1005210. doi: 10.1371/journal.pcbi.1005210. eCollection 2016.
  • Baggi F, Taybi A, Kurth A, Van Herp M, Di Caro A, Wolfel R, Gunther S, Decroo T, Declerck H, Jonckheere S. Management of pregnant women infected with Ebola virus in a treatment centre in Guinea, June 2014 Euro Surveill 2014;19(49):pii=20983. Article doi: http://dx.doi.org/10.2807/1560-7917.ES2014.19.49.20983.
  • Bah EI, Lamah M-C, Fletcher T, et al. Clinical Presentation of Patients with Ebola Virus Disease in Conakry, Guinea. N Engl J Med 2015 Jan 1;372(1):40-7. doi: 10.1056/NEJMoa1411249. Epub 2014 Nov 5
  • Baize S, Pannetier D, Oestereich L et al. Emergence of Zaire Ebola Virus Disease in Guinea- Preliminary Report, N Engl J Med 2014;371:1418-25.
  • Baize S, Pannetier D. Le diagnostic d’infection dans le cadre de la surveillance des cas d’importation en France. Dossier : Épidémie d’Ébola : Quels enseignements ? Quelles prises en charge dans les pays du sud ? adsp mars 2017;98:23-4.
  • Baize S. Problématique du diagnostic dans les pays en voie de développement : l’exemple des fièvres hémorragiques virales. Notes techniques AFD mai 2017;30:62-3.
  • Baldassi F, D'Amico F, Carestia M, Cenciarelli O, Mancinelli S, Gilardi F et al.Testing the accuracy ratio of the Spatio-Temporal Epidemiological Modeler (STEM) through Ebola haemorrhagic fever outbreaks. Epidemiol Infect 2016 May;144(7):1463-72.
  • Baldé AM, Traoré MS, Baldé MA, Barry MS, Diallo A, Camara M et al. Ethnomedical and ethnobotanical investogations ont the response capacities of guinean traditionnal health practioners outbreaks of infectious diseases : the cas of the Ebola virus epidemic. J Ethnopharmacol 2016 Feb 17. pii: S0378-8741(16)30065-4. doi: 10.1016/j.jep. 2016.02.021. [Epub ahead of print].
  • Barbe S. La recherche dans les crises humanitaires : un besoin urgent. Exemple de la réponse à l’épidémie d’Ébola par l’ONG ALIMA. Notes technique AFD mai 2017;30:81-5.
  • Barden-O'Fallon J, Barry MA, Brodish P, Hazerjian J. Rapid Assessment of Ebola-Related Implications for Reproductive, Maternal, Newborn and Child Health Service Delivery and Utilization in Guinea. PLOS Currents Outbreaks. 2015 Aug 4. Edition 1. doi: 10.1371/currents.outbreaks.0b0ba06009dd091bc39ddb3c6d7b0826.
  • Baron E, Martin B. « Je ne sais pas si cette épidémie d’Ebola était si imprévisible que cela… ». Humanitaire 2015;40:44-51.
  • Barry M, Traoré FA, Sako FB, Kpamy DO, Bah EI, Poncin M et al. Ebola outbreak in Conakry, Guinea: epidemiological, clinical, and outcome features. Med Mal Infect 2014;44:491-4.
  • Barry M, Touré A, Traoré FA, Sako FB, Sylla D, Kpamy DO et al. Clinical Predictors of Mortality in Patients With Ebola Virus Disease. Clinical Infectious Diseases 2015;60:1821-1824.
  • Bausch DG, Schwarz L. Outbreak of ebola virus disease in Guinea: where ecology meets economy PLoS Negl Trop Dis 2014;8:e3056
  • Bausch DG, Rojek A. West Africa 2013: Re-examining Ebola. Microbiol Spectr 2016 Jun;4(3). doi: 10.1128/ microbiolspec.EI10-0022-2016.
  • Bay C, Schauer A, Flusin O, Travers S. Les enjeux de la formation du personnel du Centre de traitement des soignants. Médecine et Armées 2016;44:169-72.
  • Beavogui AH, Delamou A, Yansane ML, Konde MK, Diallo AA, Aboulhab J et al. Clinical research during the Ebola virus disease outbreak in Guinea: Lessons learned and ways forward. Clin Trials 2016 Jan 14. pii: 1740774515619877. [Epub ahead of print].
  • Bedrosian SR, Young CE, Smith LA, Cox JD, Manning C, Pechta L et al. Lessons of Risk Communication and Health Promotion - West Africa and United States. MMWR 2016;65(3):68-74.
  • Bégué P. Conclusion. Séance dédiée : « Les financements innovants en matière de santé et l’épidémie à virus Ébola ». Bull Acad Natle Méd 2014;198:1533-34
  • Bekolo CE, Diallo A, Philips M, Yuma JD, Di Stefano L, Drèze S et al. Six-monthly appointment spacing for clinical visits as a model for retention in HIV Care in Conakry-Guinea: a cohort study. BMC Infect Dis 2017 Dec 13;17(1):766. doi: 10.1186/s12879-017-2826-6.
  • Bell BP, Damon IK, MD, Jernigan DB, Kenyon TA, Nichol ST, O’Connor JP et al. Overview, Control Strategies, and Lessons Learned in the CDC. Response to the 2014–2016 Ebola Epidemic. MMWR 2016;65(3):4-11.
  • Benifei S, Facon-Delahaye A, Vautier V. Crise Ebola en Guinée : quelle prise en charge psycho-sociale pour les patients et les soignants ? Rev Infirm 2016;65:34-7.
  • Benkimoun P, Potier G, Janssens M, Le Marcis F, Petibon A. Ebola : chronique d’une catastrophe annoncée. Humanitaire 2015;40:12-31.
  • Berger F, Bédubourg G, Facon A, Boyavalle S, Michel H, Velut G et al. Force health protection during the Ebola crisis : French experience in Guinea. J R Army Med Corps 2017 Feb 17;163: 223.
  • Bhatnagar N, Grover M, Kotwal A, Himanshu Chauhan H. Study of recent Ebola virus outbreak and lessons learned: A scoping study. Ann Trop Med Public Health 2016;9:145-51.
  • Bideau A. Le rôle de la Croix-Rouge dans la lutte contre Ébola. Séance dédiée : « Les financements innovants en matière de santé et l’épidémie à virus Ébola ». Bull Acad Natle Méd 2014;198:1529-31
  • Blackwood JC, Childs LM. The role of interconnectivity in control of an Ebola epidemic. Sci Rep 2016 Jul 7;6:29262. doi: 10.1038/srep29262.
  • Boëlle PY. L’épidémie en Guinée, Sierra Leone et Libéria. Dossier : Épidémie d’Ébola : Quels enseignements ? Le bilan épidémiologique. adsp mars 2017;98:12-4.
  • Boggild AK, Esposito DH, Kozarsky PE, Ansdell V, Beeching NJ, Campion D et al. Differential diagnosis of illness in travelers arriving from Sierra Leone, Liberia, or Guinea: a cross-sectional study from the GeoSentinel Surveillance Network. Ann Intern Med 2015 Jun 2;162(11):757-64.
  • Boisen ML, Hartnett JN, Goba A, Vandi MA, Grant DS, Schieffelin JS et al. Epidemiology and management of the 2013-16 West african Ebola outbreak. Annu Rev Virol 2016 Aug 15. [Epub ahead of print].
  • Bordes J, Janvier F, Aletti M, de Greslan T, Gagnon N, Cotte J et al. Organ failures on admission in patients with Ebola virus disease. Intensive Care Med 2015;41:1504-5.
  • Bordes J, Gagnon N, Cotte J, de Greslan T, Rousseaul C, Billhot M et al. Caring for critically ill patients infected with the Ebola virus caring for patients with Ebola: logistic and human challenges. Chest 2015;148:e64-5.
  • Bouchaud O. Trois petits coups de gueule et puis s’en va… Bull Soc Pathol Exot 2016;109:2016-17.
  • Bradol JH. La réponse à l’épidémie d’Ebola : négligence, improvisation et autoritarisme. Alternatives humanitaires 2016;1:39-50.
  • Breakwell L, Gerber AR, Greiner AL, Hastings DL, Mirkovic K, Paczkowski MM et al. Early Identification and Prevention of the Spread of Ebola in High-Risk African Countries. MMWR 2016;65(3):21-7.
  • Breman JG, Heymann DL, Lloyd G, McCormick JB, Miatudila M, Murphy FA et al. Discovery and Description of Ebola Zaire Virus in 1976 and Relevance to the West African Epidemic During 2013-2016. J Infect Dis 2016 Jun 29. pii: jiw207. [Epub ahead of print].
  • Briand S, Bertherat E, Cox P, Formenty P,Kieny MP, Myhre JK et al. The International Ebola Emergency. N Engl J Med 2014;371,13:1180-83
  • Bricaire F. Fièvre Ébola : « clinique ». Séance dédiée : « Les financements innovants en matière de santé et l’épidémie à virus Ébola ». Bull Acad Natle Méd 2014;198:1501-04
  • Brolin Ribacke KJ, Saulnier DD, Eriksson A, von Schreeb J. Effects of the West Africa Ebola virus disease on health-care utilization - A systematic review. Front Public Health 2016 Oct 10;4:222. eCollection 2016.
  • Brooks JC, Pinto M, MPH1 Adrienne Gill, Hills KE, Murthy S, Podgornik MN et al. Incident Management Systems and Building Emergency Management Capacity during the 2014–2016 Ebola Epidemic — Liberia, Sierra Leone, and Guinea. MMWR 2016;65(3):28-34.
  • Buchy P. Aperçu des vaccins Ebola en phase clinique et préclinique de développement. Bull Soc Pathol Exot 2016 Sep 29. doi:10.1007/s13149-016-0521-2. [Epub ahead of print].
  • Buchy P. Aperçu des vaccins Ébola en phase clinique et préclinique de développement. Bull Soc Pathol Exot 2016;109:256-61.
  • Buli BG, Mayigane LN, Oketta JF, Soumouk A, Sandouno TE, Camara B et al. Misconceptions about Ebola seriously affect the prevention efforts: KAP related to Ebola prevention and treatment in Kouroussa Prefecture, Guinea. Pan Afr Med J 2015;22 (S1):11. Published online 2015 Oct 11. doi: 10.11694/pamj.supp.2015.22.1.6269. eCollection 2015.
  • Busta ER, Mancher M, Cuff PA, McAdam K, Keusch G. Integrating clinical research into epidemic response. The Ebola experience. National Academies Press (US), Washington (DC) 2017 Jun 26. ISBN-13: 978-0-309-45776-7ISBN-10: 0-309-45776-9.
  • Calain P, Poncin M. Reaching out to Ebola victims: Coercion, persuasion or an appeal for self-sacrifice? Social Science & Medicine 2015;147:126-33 [« À la rencontre des victimes d’Ebola : coercition, persuasion ou appel au sacrifice de soi ? », version française publiée dans la même revue en mars 2016].
  • Caluwaerts S, Fautsch T, Lagrou D, Moreau M, Camara AM et al. Dilemmas in managing pregnant women with Ebola: 2 cases reports. Clin Infect Dis 2015 Dec 17. pii: civ1024. [Epub ahead of print].
  • Caluwaerts S. Nubia's mother: being pregnant in the time of experimental vaccines and therapeutics for Ebola. Reprod Health 2017 Dec 14;14(Suppl 3):157. doi: 10.1186/s12978-017-0429-8.
  • Calvignac-Spencer S, Schulze JM, Zickmann F, Renard BY. Clock rooting further demonstrates that Guinea 2014 EBOV is a member of the Zaïre lineage. PLoS Curr 2014 June 16;6:ecurrents.outbreaks.c0e035c86d721668a6ad7353f7f6fe86. doi:  10.1371/currents.outbreaks.c0e035c86d721668a6ad7353f7f6fe86
  • Calvignac-Spencer S, De Nys H, Peeters M, Leendertz FH. Maladie à virus Ebola : une zoonose orpheline ? Bull Acad Vet France 2015;68:233-38.
  • Camacho A, Eggo RM, Funk S, Watson CH, Kucharski AJ, Edmunds WJ. Estimating the probability of demonstrating vaccine efficacy in the declining Ebola epidemic: a Bayesian modelling approach. BMJ Open 2015;5:e009346.
  • Camara BS, Delamou A, Diro E, Béavogui AH, El Ayadi AM et al. Effect of the 2014/2015 Ebola outbreak on reproductive health services in a rural district of Guinea: an ecological study. Trans R Soc Trop Med Hyg 2017 Mar 18:1-8. doi: 10.1093/trstmh/trx009.
  • Camara BS, Delamou AM, Diro E, El Ayadi A, Béavogui AH, Sidibé S et al. Influence of the 2014-2015 Ebola outbreak on the vaccination of children in a rural district of Guinea. Public Health Action 2017 Jun 21;7(2):161-167. doi: 10.5588/pha.16.0120.
  • Camara A, Sow MS, Touré A, Diallo OH, Kaba I, Bah B et al. L’issue du traitement, la survie et ses facteurs de risque chez les nouveaux tuberculeux co-infectés par le VIH pendant l’épidémie d’Ebola à Conakry. Rev Epidemiol Sante Publique 2017 Oct 21. pii: S0398-7620(17)30493-5. doi: 10.1016/j.respe.2017.05.011.
  • Camara M, Ouattara E, Duvignaud A, Migliani R, Camara O, Leno M et al. Impact of the Ebola outbreak on Trypanosoma brucei gambiense infection medical activities in coastal Guinea, 2014-2015: a retrospective analysis from the Guinean national Human African Trypanosomiasis control program. PLOS Neglected Tropical Diseases 2017 November 13;11(11): e0006060. https://doi.org/10.1371/ journal.pntd.0006060.
  • Cangul M, Sdralevich C, Sian I. Beating Back. Finance & Development 2017 June:54-7.
  • Carias C, Greening B Jr, Campbell CG, Meltzer MI, Hamel MJ. Preventive malaria treatment for contacts of patients with Ebola virus disease in the context of the west Africa 2014-15 Ebola virus disease response: an economic analysis. Lancet Infect Dis 2015 Dec 16. pii: S1473-3099(15)00465-X. doi: 10.1016/S1473-3099(15)00465-X.
  • Carazo Perez S, Folkesson E, Anglaret X, Beavogui AH, Berbain E, Camara AM et al. Challenges in preparing and implementing a clinical trial at field level in an Ebola emergency: A case study in Guinea, West Africa. PLoS Negl Trop Dis 2017 Jun 22;11(6):e0005545. doi: 10.1371/journal.pntd.0005545. eCollection 2017 Jun.
  • Carrión Martín AI, Derrough T, Honomou P, Kolie N, Diallo B, Koné M et al. Social and cultural factors behind community resistance during an Ebola outbreak in a village of the Guinean Forest region, February 2015: a field experience. Int Health 2016 Apr 7. pii: ihw018.
  • Carroll JW, Matthews DA, Hiscox JA et al. Temporal and spatial analysis of the 2014–2015 Ebola virus outbreak in West Africa. Nature 2015; doi:10.1038/nature14594.
  • Carroll MW, Haldenby S, Rickett NY, Pályi B, Garcia-Dorival I, Liu X et al. Deep Sequencing of RNA from Blood and Oral Swab Samples Reveals the Presence of Nucleic Acid from a Number of Pathogens in Patients with Acute Ebola Virus Disease and Is Consistent with Bacterial Translocation across the Gut. mSphere 2017 Aug 23;2(4). pii: e00325-17. doi: 10.1128/mSphereDirect.00325-17. eCollection 2017 Jul-Aug.
  • Cellarier G, Bordes J, Karkowski L, Gagnon N, Billhot M, Cournac JM et al. Safety, feasibility, and interest of transthoracic echocardiography in a deployed French military Ebola virus disease treatment center in Guinea. Intensive Care Med 2015 Aug;41(8):1491-2.
  • Cellarier G, Bordes J, De Greslan T, Karkowski L, Gagnon N, Billhot M et al. Inappropriate bradycardia in Ebola virus disease. Med Sante Trop 2016 Aug 1;26(3):283-286.
  • Cenciarelli O, Pietropaoli S, Malizia A, Carestia M, D'Amico F, Sassolini A et al. Ebola virus disease 2013-2014 outbreak in west Africa: an analysis of the epidemic spread and response. Int J Microbiol 2015;2015:769121.
  • Chandler C, Fairhead J, Kelly A, Leach M, Martineau F, Mokuwa E et al. Ebola: limitations of correcting misinformation. The Lancet 2015;38:1275-77.
  • Chaple EB, Mercer MA. The cuban response to the Ebola epidemic in West Africa: Lessons in solidarity. Int J Health Serv 2017 Jan;47(1):134-149.
  • Chapman HJ, Animasahun VJ, Tade AE, Naveed A. Addressing the role of medical students using community mobilization and social media in the Ebola response. Perspect Med Educ 2016. doi: 10.1007/s40037-016-0271-7.
  • Chérif MS, Koonrungsesomboon N, Kassé D, Cissé SD, Diallo SB, Chérif F et al. Ebola virus disease in children during the 2014-2015 epidemic in Guinea: a nationwide cohort study. Eur J Pediatr 2017 Apr 25. doi: 10.1007/s00431-017-2914-z.
  • Cherif MS, Dumre SP, Kassé D, Cherif F, Camara F, Koné A, et al. Prognostic and Predictive Factors of Ebola Virus Disease Outcome in Elderly People during the 2014 Outbreak in Guinea. Am J Trop Med Hyg 2017 Oct 30. doi: 10.4269/ajtmh.17-0372. [Epub ahead of print].
  • Chidiac C, Grandbastien B. Maladie à virus Ébola : qu’avons-nous appris de cette crise. Dossier : Épidémie d’Ébola : Quels enseignements ? Editorial. Actualité et dossier de santé publique (adsp) mars 2017;98:2-3.
  • Chidiac C, Rapp C. Les aspects cliniques de la maladie. Dossier : Épidémie d’Ébola : Quels enseignements ? Le bilan épidémiologique. adsp mars 2017;98:14-8.
  • Chidiac C, Rapp C. Leçons des suivis de cohorte : résurgences virales. Dossier : Epidémie d’Ébola : Quels enseignements ? La recherche. adsp mars 2017;98: 39-43.
  • Chowell G, Nishiura H. Characterizing the Transmission Dynamics and Control of Ebola Virus Disease. PLOS Biology 2015 Jan 21. DOI:10.1371/journal.pbio.1002057
  • Chretien JP, Riley S, George DB. Mathematical modeling of the West Africa Ebola epidemic. Elife 2015 Dec 8;4. pii: e09186. doi: 10.7554/eLife.09186. [Epub ahead of print].
  • Cimini E, Viola D, Cabeza-Cabrerizo M, Romanelli A, Tumino N et al. Different features of Vδ2 T and NK cells in fatal and non-fatal human Ebola infections. PLoS Negl Trop 2017 May 30. Dis 11(5): e0005645. https://doi.org/10.1371/journal.pntd.0005645.
  • Cleaton JC, Viboud C, Simonsen L, Hurtado AM, Chowell G. Characterizing Ebola transmission patterns based on internet news reports. Clin Infect Dis 2015 Sep 3. pii: civ748. [Epub ahead of print]
  • Cohen NJ, Brown CM, Alvarado-Ramy F, Bair-Brake H, Benenson GA, Chen TH et al. Travel and Border Health Measures to Prevent  the International Spread of Ebola. MMWR 2016;65(3):57-67.
  • Coller BG, Blue J, Das R, Dubey S, Finelli L, Gupta S et al. Clinical development of a recombinant Ebola vaccine in the midst of an unprecedented epidemic. Vaccine 2017 Aug 16;35:4465-4469. doi: 10.1016/j.vaccine.2017.05.097. Epub 2017 Jun 21.
  • Coltart CEM, Edmunds WJ, Atkins KE. The 2013–2016 Ebola epidemic: multidisciplinary success conceals a missed opportunity. Phil Trans R Soc B 2017;372:20160292.
  • Coltart CEM, Lindsey B, Ghinai I, Johnson AM, Heymann DL. The Ebola outbreak, 2013–2016: old lessons for new epidemics. Phil Trans R Soc 2017. B 372:20160297. http://dx.doi.org/10.1098/rstb.2016.0297.
  • Cotte J, Cordier PY, Bordes J, Janvier F, Esnault P, Kaiser E et al. Fluid resuscitation in Ebola Virus Disease: A comparison of peripheral and central venous accesses. Anaesth Crit Care Pain Med 2015 Nov 2. pii: S2352-5568(15)00118-6. doi: 10.1016/j.accpm.2015.06.010. [Epub ahead of print].
  • Cotte J, Bordes J, Cordier PY, Gagnon N. Défaillance d’organes au cours de la maladie àvirus Ebola : étude rétrospective au Centre de traitement des soignants de Conakry. Médecine et Armées 2016;44:181-5.
  • Cournac JM, Karkowski L, Bordes J, Aletti M, Duron S, Janvier F et al. Rhabdomyolysis in Ebola virus disease. Results of an observational study in a treatment center in Guinea. Clin Infect Dis 2015 Sep 3. pii: civ779. [Epub ahead of print].
  • Crop M, Delamou A, Griensven JV, Ravinetto R. Multiple ethical review in North-South collaborative research: the experience of the Ebola-Tx trial in Guinea. Indian J Med Ethics 2016 Jan 25;-(-):1-7. [Epub ahead of print].
  • Cros M. Du sida à Ébola : Rites de mort à fonction apotropaïque. L’autre, cliniques, cultures et sociétés 2015;16:263-74.
  • Dahl BA, Kinzer MH, Raghunathan PL, Christie A, De Cock KM, Mahoney F et al. CDC’s Response to the 2014–2016 Ebola Epidemic — Guinea, Liberia, and Sierra Leone. MMWR 2016;65(3):12-20.
  • De Bort C. L’engagement d’Eprus dans la lutte contre la maladie Ébola. Dossier : Épidémie d’Ébola : Quels enseignements ? Quelles prises en charge dans les pays du sud ? adsp mars 2017;98:25.
  • de Greslan T, Billhot M, Rousseau C, Mac Nab C, Karkowski L, Cournac JM, Bordes J et al. Ebola virus related encephalitis. Clin Infect Dis 2016 Jul 14. pii: ciw469. [Epub ahead of print].
  • Debord T. Ébola : le rôle de la Task force interministérielle en France. Dossier : Épidémie d’Ébola : Quels enseignements ? Les prises en charge dans les pays du Nord. adsp mars 2017;98:26-9.
  • Dedkov VG, Magassouba NF, Safonova MV, Deviatkin AA, Dolgova AS, Pyankov OV et al. 
  • Development and evaluation of a real-time RT-PCR assay for the detection of Ebola virus (Zaire) during an Ebola outbreak in Guinea in 2014-2015. J Virol Methods 2015 Nov 17. pii: S0166-0934(15)00361-4.
  • Delamou A, Haba NY, Mari-Saez A, Galliant P, Ronse M, Jacobs J et al. Organizing the donation of convalescent plasma for a therapeutic clinical trial on Ebola virus disease: The experience in Guinea. Am J Trop Med Hyg 2016 Jul 18. pii: 15-0890. [Epub ahead of print].
  • Delamou A, Camara BS, Kolie JP, Guemou AD, Haba NY, Marquez S et al. Profile and reintegration experience of Ebola survivors in Guinea: a cross-sectional study. Trop Med Int Health 2016 Dec 9. doi: 10.1111/tmi.12825. [Epub ahead of print].
  • Delamou A, El Ayadi AM, Sidibe S, Delvaux T, Camara BS, Sandouno SD et al. Effect of Ebola virus disease on maternal and child health services in Guinea: a retrospective observational cohort study. Lancet Glob Health Published online February 22, 2017 http://dx.doi.org/10.1016/S2214-109X(17)30078-5.
  • Delamou A, Delvaux T, El Ayadi AM, Beavogui AH, Okumura J, Van Damme W et al. Public health impact of the 2014-2015 Ebola outbreak in West Africa: seizing opportunities for the future. BMJ Glob Health 2017 Mar 16;2(2):e000202. doi: 10.1136/bmjgh-2016-000202. eCollection 2017 Mar.
  • Delaune D, Janvier F, Foissaud V, Gaillard T, Flusin O, Dubrous P et al. Le laboratoire du Centre de traitement des soignants. Médecine et Armées 2016;44:173-80.
  • Delfraissy JF, Miribel B. Les leçons d’Ebola. Alternatives humanitaires 2016;1:22-7.
  • Delfraissy JF. Éditorial : Ébola 2014-2015, une crise sanitaire majeure. Pourquoi ? Quelles leçons ? Santé Publique 2017 Oct 2;29(4):497-507. Doi: 10.3917/spub.174.0447.
  • Desclaux A, Sow K. Des anthropologues face à l’épidémie d’Ebola. Colloque EBODAKAR : « Épidémie d’Ebola en Afrique de l’Ouest. Approches ethno-sociales comparées », Dakar, 19-21 mai 2015, Le Journal des Anthropologues 2016;144-145 :263-269, en ligne, https://jda.revues.org/6452.
  • Desclaux A, Diop M, Doyon S. Fear and containment. Contact follow up perceptions and social effects in Senegal and Guinea. In : Au S, Hofman M (eds), The politics of fear: MSF and the West African Ebola epidemic, Oxford University Press, 2017.
  • Desclaux A, Diop M, Doyon S. Peur et confinement. Perceptions du suivi des contacts et effets sociaux au Sénégal et en Guinée. In : Au S, Hofman M (eds), La politique de la peur: MSF et l’épidémie d’Ébola en Afrique de l’ouest, 2017, Editions Renaissance du livre, pp. 277-306 (version française).
  • Desclaux A, Anoko J. L’anthropologie engagée dans la lutte contre Ébola (2014-2016) : approches, contributions et nouvelles questions. Santé Publique 2017 Oct 2;29(4):477-485. doi:10.3917/spub.174.0477.
  • Dhillon RS, Kelly JD. Community trust and the Ebola endgame. N Engl J Med 2015;373:387-89.
  • Diakite AS. L’épidémie à virus Ébola en Guinée, ses conséquences sanitaires et socio-économiques. Séance dédiée : « Les financements innovants en matière de santé et l’épidémie à virus Ébola ». Bull Acad Natle Méd 2014;198:1505-14
  • Diakite AS. Ebola en Guinée : un révélateur des forces et faiblesses. Alternatives humanitaires 2016;1:57-65.
  • Diallo B, Sissoko D, Loman NJ, Bah HA, Bah H, Worrell MC, Conde LS et al. Resurgence of Ebola virus disease in Guinea linked to a survivor with virus persistence in seminal fluid for more than 500 days. Clin Infect Dis 2016 Sep 1. pii: ciw601. [Epub ahead of print].
  • Dindart JM, Peyrouset O, Palich R, Bing A, Kojan R, Barbe S et al. Aerial medical evacuation of health workers with suspected Ebola virus disease in Guinea Conakry-interest of a negative pressure isolation pod-a case series. BMC Emerg Med 2017 Mar 11;17(1):9. doi: 10.1186/s12873-017-0121-x.
  • Dixon MG, Taylor MM, Dee J, Hakim A, Cantey P, Lim T et al. Contact Tracing Activities during the Ebola Virus Disease Epidemic in Kindia and Faranah, Guinea, 2014. Emerg Infect Dis 2015 Nov;21(11):2022-28.
  • Dong F, Xu D, Wang Z, Dong M. Evaluation of Ebola spreading in West Africa and decision of optimal medicine delivery strategies based on mathematical models. Infect Genet Evol 2015 Sep 4. pii: S1567-1348(15)00370-6. doi: 10.1016/j.meegid.2015.09.003. [Epub ahead of print]
  • Donne KA. West African Ebola epidemic: lessons and a call to action. Pan Afr Med J 2015;22(S1):2. Published online 2015 Oct 10. doi:  10.11694/pamj.supp.2015.22.1.6040.
  • Dopson SA, Rodriguez R, Rouse EN. Providing Logistics Support to CDC-Deployed Staff for the Ebola Response in Liberia, Guinea, and Sierra Leone. Health Promot Pract 2015 Sep 18. pii: 1524839915605513. [Epub ahead of print].
  • Dörnemann J, Burzio C, Ronsse A, Sprecher A, De Clerck H, Van Herp M et al. First newborn baby to receive experimental therapies survives Ebola virus disease. J Infect Dis 2017 Jan 9. pii: jiw493. doi: 10.1093/infdis/jiw493. [Epub ahead of print].
  • D’Ortenzio E, Yazdanpanah Y. Ebola : les progrès de la recherche clinique pendant l’épidémie. 
  • Dossier : Épidémie d’Ébola : Quels enseignements ? La recherche. adsp mars 2017;98:36-8.
  • Douste-Blazy P. Solidarité mondiale ou guerre mondiale ? Séance dédiée : « Les financements innovants en matière de santé et l’épidémie à virus Ébola ». Bull Acad Natle Méd 2014;198:1483-86
  • D’Silva JP, Eisenberg MC. Modeling Spatial Invasion of Ebola in West Africa. Journal of Theoretical Biology 2017 May 23. doi: 10.1016/j.jtbi.2017.05.034.
  • Dudas G, Rambaut A. Phylogenetic analysis of Guinea 2014 EBOV Ebolavirus outbreak. PLoS Curr 2014 May 2.
  • Dudas G, Carvalho LM, Bedford T, Tatem AJ, Baele G, Faria NR et al. Virus genomes reveal factors that spread and sustained the Ebola epidemic. Nature 2017 Apr 12. doi: 10.1038/nature22040.
  • Dufour-Gaume F, Delaune D, Martinaud C, Sailliol A.Early and repeated use of plasma for the management of Ebola patients: Reflection around a case. Transfus Clin Biol 2016 Sep 14. pii: S1246-7820(16)30040-4. doi: 10.1016/j.tracli.2016.08.005. [Epub ahead of print].
  • Durski KN, Singaravelu S, Teo J, Naidoo D, Bawo L, Jambai A et al. The development, use, and impact of a global laboratory database during the 2014 Ebola outbreak in West Africa. J Infect Dis 2017 May 18. doi: 10.1093/infdis/ jix236.
  • Ébola Ça Suffit Ring Vaccination Trial Consortium. The ring vaccination trial: a novel cluster randomised controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola. BMJ 2015;351:h3740.
  • Edelstein M, Heymann DL. Ébola : passé, présent et futur. Alternatives humanitaires 2016;1:28-37.
  • Edward C, Holmes EC, Dudas G, Rambaut A, Andersen KG. The evolution of Ebola virus: insights from the 2013-2016 epidemic. Nature 2016;538;193-200.
  • Edwards T, Semple MG, De Weggheleire A, Claeys Y, De Crop M, Menten J et al. Design and analysis considerations in the Ebola_Tx trial evaluating convalescent plasma in the treatment of Ebola virus disease in Guinea during the 2014-2015 outbreak. Clin Trials 2016 Jan 14. pii: 1740774515621056. [Epub ahead of print].
  • Eggo RM, Watson CH, Camacho A, Kucharski AJ, Funk S, Edmunds WJ. Duration of Ebola virus RNA persistence in semen of survivors: population-level estimates and projections. Euro Surveill 2015;20(48):30083. doi: 10.2807/1560-7917.ES.2015.20.48.30083.
  • Ellerbrok H, Jacobsen S, Patel P, Rieger T, Eickmann M, Becker S et al. External quality assessment study for ebolavirus PCR-diagnostic promotes international preparedness during the 2014 - 2016 Ebola outbreak in West Africa. PLoS Negl Trop Dis 2017 May 1;11(5):e0005570. doi: 10.1371/journal.pntd.0005570.
  • Elston JWT, Cartwright C, Ndumbi P, Wright J. The health impact of the 2014e15 Ebola outbreak. Public Health 2017;143:60-70.
  • Emrick P, Gentry C, Morowit L. Ebola Virus Disease: international perspective on enhanced health surveillance, disposition of the dead, and their effect on isolation and quarantine practices. Disaster and Mil Med 2016;2:13. doi: 10.1186/s40696-016-0023-6.
  • Enanoria WTA, Worden L, Liu F, Gao D, Ackley S et al. Evaluating subcriticality during the Ebola epidemic in West Africa. PLoS One 2015 Oct 20;10(10):e0140651.
  • Enserink M. Infectious diseases. In Guinea, a long, difficult road to zero Ebola cases. Science 2015 May 1;348(6234):485-6.
  • Epelboin A. La maladie à virus Ébola : un passé dramatique et un futur incertain. Bull Soc Pathol Exot 2016;109:213-15.
  • Etard JF, Sow MS, Leroy S, Touré A, Taverne B, Keita AK et al. Multidisciplinary assessment of post-Ebola sequelae in Guinea (Postebogui): an observational cohort study. Lancet Infect Dis 2017 may;17(5):545–552. http://dx.doi.org/10.1016/S1473-3099(16)30516-3.
  • Etard JF, Barry M, Delaporte E for the Postebogui study group. Life after Ebola in Guinea – The Postebogui cohort. Infectious Disease Hub 2017, https://www.id-hub.com/2017/03/13/life-ebola-guinea-postebogui-cohort/
  • Fages C, Lévy Y, Delfraissy JF. La Task Force interministérielle Ébola : la vision internationale (2014-2015). Dossier : Épidémie d’Ébola : Quels enseignements ? Quelles prises en charge dans les pays du sud ? adsp mars 2017;98:19-23.
  • Fairhead J. Understanding social resistance to Ebola response in Guinea. African Studies Review 2016 December;59:7-31.
  • Fairley JK, Kozarsky PE, Kraft CS, Guarner J, Steinberg JP, Anderson E et al. Ebola or Not? Evaluating the Ill Traveler From Ebola-Affected Countries in West Africa. Open Forum Infect Dis 2016 Jan 18;3(1):ofw005. doi: 10.1093/ofid/ ofw005. eCollection 2016.
  • Fasina FO, Adenubi OT, Ogundare ST, Shittu A, Bwala DG, Fasina MM. Descriptive analyses and risk of death due to Ebola Virus Disease, West Africa, 2014. J Infect Dev Ctries 2015 Dec 30;9(12):1298-307. doi: 10.3855/jidc.6484.
  • Faye O, Boëlle PY, Heleze E, Faye O, Loucoubar C, Magassouba N et al. Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: an observational study. Lancet Infect Dis 2015; S1473-3099:71075-8
  • Faye O, Faye O, Soropogui B, Patel P, El Wahed AA, Loucoubar C et al. Development and deployment of a rapid recombinase polymerase amplification Ebola virus detection assay in Guinea in 2015. Euro Surveill 2015;20(44):10-8.
  • Faye O, Andronico A, Faye O, Salje H, Boëlle PY, Magassouba N et al. Use of viremia to evaluate the baseline case fatality ratio of Ebola virus disease and inform treatment studies: a retrospective cohort study. PLOS Medicine 2015, Dec 1. DOI:10.1371/journal.pmed.1001908.
  • Fernandez-Garcia MD, Majumdar M, Kebe O, Fall AD, Kone M, Kande M et al. Emergence of Vaccine-Derived Polioviruses during Ebola Virus Disease Outbreak, Guinea, 2014-2015. Emerg Infect Dis 2018 Jan;24(1):65-74. doi: 10.3201/eid2401.171174.
  • Ferraris O, Reynard A, Ferrier A, Emonet S, Drouet I, Jarjaval F et al. La fièvre hémorragique à virus Ebola : généralités sur le virus et rôle d’une unité militaire de recherche en virologie au cours d’une épidémie. Médecine et Armées 2016;44:111-9.
  • Ficko C, Dubost C, Bigaillon C, Feuillette C, Moreau N, Delacour H et al. Prise en charge de cas confirmés de maladie à virus Ebola à l’hôpital d’instruction des armées Bégin : l’aboutissement d’une préparation multidisciplinaire. Médecine et Armées 2016;44:143-8.
  • Fischer RJ, Bushmaker T, Judson S, Munster VJ. Comparison of the aerosol stability of 2 strains of Zaire ebolavirus from the 1976 and 2013 outbreaks. J Infect Dis 2016 Aug 8. pii: jiw193. [Epub ahead of print].
  • Fitzpatrick G, Decroo T, Draguez B, Crestani R,  Ronsse A, Van den Bergh R et al. Operational Research during  the Ebola Emergency. Emerg Infect Dis 2017 July;23(7):1057-62.
  • Fortin A, Vroh Benie Bi J, Soulimane A. Les enseignements de l’épidémie d’Ébola pour une meilleure préparation aux urgences. Santé Publique 2017 Oct 2;29(4):465-475. doi:10.3917/spub.174.0465.
  • Fribault M. Ebola en Guinée : violences historiques et régimes de doute. Anthropologie & Santé [En ligne] 2015 : mis en ligne le 30 novembre 2015. URL : http://anthropologiesante.revues.org/1761. doi: 10.4000/anthropologiesante .1761.
  • Frieden TR, Damon IK. Ebola in West Africa-CDC's Role in Epidemic Detection, Control, and Prevention. Emerg Infect Dis 2015 Nov;21(11):1897-905.
  • Frieden TR. CDC’s Response to the 2014–2016. Ebola Epidemic — West Africa and United States. Foreword. MMWR 2016;65(3):1-3.
  • Fung IC, Fu KW, Chan CH, Chan BS, Cheung CN, Abraham T, Tse ZT. Social media's initial reaction to information and misinformation on Ebola, August 2014: facts and rumors. Public Health Rep 2016 May-Jun;131(3):461-73.
  • Gaillard T, Delaune D, Flusin O, Paucod JC, Richard S, Boubis L et al. Decontamination of a field laboratory dedicated to Ebola virus-infected patients. Am J Infect Control 2016 Aug 26. pii: S0196-6553(16)30692-7. doi: 10.1016/j.ajic.2016.05.034. [Epub ahead of print].
  • Gallais F, Gay-Andrieu F, Picot V, Magassouba N, Mély S, Peyrefitte CN et al. Field Assessment of the new rapid diagnostic test Ebola eZYSCREEN®. Bull Soc Pathol Exot 2017 Jan 3. doi: 10.1007/s13149-016-0540-z. [Epub ahead of print].
  • Garbuglia AR. Ebola epidemic of 2014-2015: unresolved ethical issues. Indian J Med Ethics 2016 Feb 17;-(-):1-7. [Epub ahead of print].
  • Garske T, Cori A, Ariyarajah A, Blake IM, Dorigatti I, Eckmanns T et al. Heterogeneities in the case fatality ratio in the West African Ebola outbreak 2013-2016. Philos Trans R Soc Lond B Biol Sci 2017 May 26;372(1721). pii: 20160308. doi: 10.1098/rstb.2016.0308.
  • Gasper S. De la métropole à la Guinée … Médecine et Armées 2016;44:203-4.
  • Gasquet-Blanchard C. Ebola, géographie d'un virus. Enjeux socio-spatiaux en Afrique Centrale. L'Espace Politique 2015;26, mis en ligne le 22 juillet 2015. http://www.espacepolitique.revues.org/3475
  • Gasquet-Blanchard C. L’épidémie d’Ébola de 2013-2016 en Afrique de l’Ouest : analyse critique d’une crise avant tout sociale. Santé Publique 2017 Oct 2;29(4):453-464. doi:10.3917/spub.174.0453.
  • Gautier L, Houngbedji KA, Uwamaliya J, Coffee M. Use of a community-led prevention strategy to enhance behavioral changes towards Ebola virus disease prevention: a qualitative case study in Western Côte d'Ivoire. Glob Health Res Policy 2017 Dec 22;2:35. doi: 10.1186/s41256-017-0055-6. eCollection 2017.
  • Gaüzère BA, Ouellet I, Nottebrock D, Nied JC, Beya-Kadiebwe B, Camara AK et al. Apport d’un laboratoire dans la prise en charge des patients atteints de la maladie à virus Ébola et dans la formation des personnels soignants : expérience du Centrede traitement d’Ebola de Forécariah (Guinée) en 2015. Bull Soc Pathol Exot 2016;109:248-55.
  • Gaüzère BA, Ouellet I, Nottebrock D, Nied JC, Beya-Kadiebwe B, Camara AK et al. Bilan d’activité du centre de traitement Ébola de Forécariah (Guinée) du 23 avril au 5 juin 2015 : analyse et réflexions. Bull Soc Pathol Exot 2016;109:272-80.
  • Gaüzère BA, Ouellet I, Nottebrock D, Nied JC, Beya-Kadiebwe B, Keira Camara A et al. En visite au centre de traitement Ébola de Forécariah (Guinée) du 23 avril au 5 juin 2015. Urgences et crises sanitaires dans les pays à ressources limitées : de la préparation à la réponse. Chapitre trois. Focale sur l’épidémie de fièvre hémorragique à virus Ébola en Afrique de l’Ouest (2013-2016). Notes techniques AFD mai 2017;30:57-61.
  • Gay-Andrieu F, Magassouba N, Picot V, Phillips CL, Peyrefitte CN, Dacosta B et al. Clinical evaluation of the BioFire FilmArray® BioThreat-E test for the diagnosis of Ebola Virus Disease in Guinea. J Clin Virol 2017 May 1;92:20-24. doi: 10.1016/j.jcv.2017.04.015.
  • Gentilini M. Introduction. Séance dédiée : « Les financements innovants en matière de santé et l’épidémie à virus Ébola ». Bull Acad Natle Méd 2014;198:1487-91
  • Gentilini M, Bégué P. Recommandations. À propos de l’épidémie à virus Ébola. Séance dédiée : « Les financements innovants en matière de santé et l’épidémie à virus Ébola ». Bull Acad Natle Méd 2014;198:1535-36
  • Gillespie AM, Obregon R, El Asawi R, Richey C, Manoncourt E, Joshi K et al. Social mobilization and community engagement central to the Ebola response in West Africa: Lessons for Future Public Health Emergencies. Glob Health Sci Pract 2016 Dec 28;4(4):626-646. doi: 10.9745/GHSP-D-16-00226. Print 2016 Dec 23.
  • Glynn JR. Age-specific incidence of Ebola virus disease. Lancet 2015 Aug 1;386(9992):432.
  • Gomez-Barroso D, Velasco E, Varela C, Leon I, Cano R. Spread of Ebola virus disease based on the density of roads in West Africa. Geospat Health 2017 Nov 3;12(2):552. doi: 10.4081/gh.2017.552.
  • Gostin LO, Friedman EA. A retrospective and prospective analysis of the west African Ebola virus disease epidemic: robust national health systems at the foundation and an empowered WHO at the apex. Lancet 2015 May 9;385(9980):1902-9. doi: 10.1016/S0140-6736(15)60644-4.
  • Greiner AL, Angelo KM, McCollum AM, Mirkovic K, Arthur R, Angulo FJ. Addressing contact tracing challenges - Critical to halting Ebola virus disease transmission. Int J Infect Dis 2015 Nov 4. pii: S1201-9712(15)00259-3. doi: 10.1016/ j.ijid.2015.10.025. [Epub ahead of print].
  • Grélot L, Koulibaly F, Maugey N, Janvier F, Foissaud V, Aletti M et al. Moderate thermal strain in healthcare workers wearing personal protective equipment during treatment and care activities in the context of the 2014 Ebola virus disease outbreak. J Infect Dis 2015 Dec 9. pii: jiv585. [Epub ahead of print].
  • Grinnell M, Dixon MG, Patton M, Fitter D, Bilivogui P, Johnson C et al. Ebola Virus Disease in Health Care Workers - Guinea, 2014. MMWR 2015 Oct 2;64:1083-7.
  • Grünewald F. Ebola : comment le virus est sorti de la clairière. Humanitaire 2015;40:32-43.
  • Gsell PS, Camacho A, Kucharski AJ, Watson CH, Bagayoko A, Danmadji S et al. Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in 
  • Guinea, 2016: an operational and vaccine safety report. Lancet Infect Dis 2017 Oct 9. pii: S1473-3099(17)30541-8. doi: 10.1016/S1473-3099(17)30541-8. [Epub ahead of print].
  • Guo Z, Xiao D, Li D, Wang X, Wang Y, Yan T et al. Predicting and evaluating the epidemic trend of Ebola virus disease in the 2014-2015 outbreak and the effects of intervention measures. PloS One 2016 Apr 6. doi:10.1371/journal.pone.0152438.
  • Hageman JC, Hazim C, Wilson K, Malpiedi P, Gupta N, Bennett S et al. Infection Prevention and Control for Ebola in Health Care Settings — West Africa and United States. MMWR 2016;65(3):50-6.
  • Hayden FG, Friede M, Bausch DG. Experimental Therapies for Ebola Virus Disease: What Have We Learned? JID 2017:215;167-70.
  • Helleringer S, Noymer A. Magnitude of Ebola relative to other causes of death in Liberia, Sierra Leone, and Guinea. Lancet Glob Health 2015 May;3(5):e255-6.
  • Henao-Restrepo AM, Longini IM, Egger M, Dean NE, Edmunds WJ, Camacho A et al. Efficacy and effectiveness of an rVSV-vectored vaccine expressing Ebola surface glycoprotein: interim results from the Guinea ring vaccination cluster-randomised trial. The Lancet 2015;386:857-66.
  • Henao-Restrepo AM, Camacho A, Longini IM, Watson CH, Edmunds WJ, Egger M et al. Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ça Suffit!). Lancet 2016 Dec 22. pii: S0140-6736(16)32621-6. doi: 10.1016/S0140-6736(16)32621-6. [Epub ahead of print].
  • Hereth-Hébert E, Toure A, Sow M, Barry M, Etard J, Delaporte E. Complications ophtalmologiques de l’infection à virus Ebola. Médecine Mal Infect 2016;46(4 Suppl 1):18.
  • Hereth-Hebert E, Bah MO, Etard JF, Sow MS, Resnikoff S, Fardeau C et al. Ocular complications in survivors of the Ebola outbreak in Guinea. American Journal of Ophthalmology 2017;175:114-21.
  • Hereth-Hebert E, Resnikoff S, March L, Delaporte E. Ocular Complications in survivors of the Ebola outbreak in Guinea. Am J Ophthalmol 2017 Jul 31. pii: S0002-9394(17)30289-1. doi: 10.1016/j.ajo.2017.06.032.
  • Hersey S, Martel L, Jambai A, Keita S, Yoti Z, Meyer E. Ebola Virus Disease - Sierra Leone and Guinea, August 2015. MMWR Sept. 2015;64:981-84.
  • Higgs ES, Dubey SA. Accelerating Vaccine Development During the 2013-2016 West African Ebola Virus Disease Outbreak. Curr Top Microbiol Immunol 2017 Sep 17.
  • Hivert F. La Protection Civile : une opportunité supplémentaire pour la coopération française en Afrique. CDEC/DDO – Lettre du Retex – Opérations 2017 mai;33:1-7.
    Honigsbaum M. Between Securitisation and Neglect: Managing Ebola at the Borders of Global 
  • Health. Med Hist 2017 Apr;61(2):270-294.
  • Horby PW, Endzt H, Muyembe-Tamfum JJ, van Griensven J, Gevao S, Goossens H et al. Ebola: Europe-Africa research collaborations. Lancet Infect Dis 2015 Nov;15(11):1258-9.
  • Hossmann S, Haynes AG, Spoerri A, Diatta ID, Aboubacar B, Egger M et al. Data management of clinical trials during an outbreak of Ebola virus disease. Vaccine 2017 Oct 23. pii: S0264-410X(17)31367-1. doi: 10.1016/j.vaccine.2017.09.094. [Epub ahead of print].
  • Hsieh YH. Temporal Course of 2014 Ebola virus disease (EVD) outbreak in west Africa elucidated through morbidity and mortality data: a tale of three countries. PloS One 2015 November 11. doi:10.1371/journal. pone.0140810.
  • Hsu CH, Champaloux SW, Keïta S, Martel L, Bilivogui P, Knust B et al. Sensitivity and Specificity of Suspected Case Definition Used during West Africa Ebola Epidemic. Emerg Infect Dis 2018 Jan;24(1):9-14. doi: 10.3201/eid2401.161678.
  • Huang JY, Louis FJ, Dixon MG, Sefu M, Kightlinger L, Martel LD et al. Notes from the Field: Baseline Assessment of the Use of Ebola Rapid Diagnostic Tests - Forécariah, Guinea, October-November 2015. Morb Mortal Wkly Rep 2016;65(12):328-329.
  • Ingelbeen B, Bah EI, Decroo T, Balde I, Nordenstedt H, van Griensven J et al. Mortality among PCR negative admitted Ebola suspects during the 2014/15 outbreak in Conakry, Guinea: A retrospective cohort study. PLoS One 2017 Jun 30;12(6):e0180070. doi: 10.1371/journal.pone.0180070. eCollection 2017.
  • Irenge LM, Dindart JM, Gala JL. Biochemical testing in a laboratory tent and semi-intensive care of Ebola patients on-site in a remote part of Guinea: a paradigm shift based on a bleach-sensitive point-of-care device. Clin Chem Lab Med 2017 Mar 15. pii: /j/cclm.ahead-of-print/cclm-2016-0456/cclm-2016-0456.xml. doi: 10.1515/cclm-2016-0456.
  • Irwin KL, Jalloh MF, Corker J, Alpha Mahmoud B, Robinson SJ, Li W et al. Attitudes about vaccines to prevent Ebola virus disease in Guinea at the end of a large Ebola epidemic: Results of a national household survey. Vaccine 2017 Jul 14. pii: S0264-410X(17)30803-4. doi: 10.1016/j.vaccine.2017.06.026.
  • Ivorra B, Ngom D, Ramos AM. Be-CoDiS: A mathematical model to predict the risk of human diseases spread between countries—Validation and application to the 2014–2015 Ebola Virus Disease epidemic. Bull Math Biol 2015 Oct 8. [Epub ahead of print].
  • Jabot F, Kane H. Du temps de l’urgence à celui de la réflexion : requestionner les approches de santé publique après Ébola. Santé Publique 2017 Oct 2;29(4):451-452. doi:10.3917/spub.174.0451.
  • Jalloh MF, Bunnell R, Robinson S, Jalloh MB, Barry AM, Corker J et al. Assessments of Ebola knowledge, attitudes and practices in Forécariah, Guinea and Kambia, Sierra Leone, July-August 2015. Philos Trans R Soc Lond B Biol Sci 2017 May 26;372(1721). pii: 20160304. doi: 10.1098/rstb.2016.0304.
  • Jalloh MF, Robinson SJ, Corker J, Li W, Irwin K, Barry AM et al. Knowledge, Attitudes, and Practices Related to Ebola Virus Disease at the End of a National Epidemic - Guinea, August 2015. Morb Mortal Wkly Rep 2017 Oct 20;66(41):1109-1115. doi: 10.15585/mmwr.mm6641a4.
  • Janvier F, Gorbatch S, Queval L, Top J, Vigier C et al. Difficulties of interpretation of Zaire Ebola Virus PCR results and implication in the field. J Clin Virol 2015 Jun;67:36-7.
  • Janvier F, Foissaud V, Delaune D, Flusin O, Dubrous P, Nab CM et al. Deployment of the french military field laboratory dedicated to Ebola virus infected patients in Guinea, January 2015 to July 2015. J Infect Dis 2015 Nov 23. pii: jiv554.
  • Janvier F, Sagui E, Foissaud V. ReEBOV Antigen Rapid Test kit for Ebola. Lancet 2015;386:2254-5.
  • Janvier F, Delaune D, Poyot T, Valade E, Mérens A, Rollin PE et al. Ebola Virus RNA Stability in Human Blood and Urine in West Africa’s Environmental Conditions. Emerg Infect Dis 2016;22(2):292-94.
  • Jean Louis F, Huang JY, Nebie YK, Koivogui L, Jayaraman G, Abiola N et al. Implementation of broad screening with Ebola rapid diagnostic tests in Forécariah, Guinea. Afr J Lab Med 2017 Mar 31;6(1):484. doi: 10.4102/ajlm.v6i1.484. eCollection 2017.
  • Ka D, Fall G, Diallo VC, Faye O, Fortes LD, Faye O et al. Ebola Virus Imported from Guinea to Senegal, 2014. Emerg Infect Dis 2017 Jun;23(6):1026-1028. doi: 10.3201/eid2306.161092.
  • Kang J, Tyan KS, Jin K, Kyle AM. Field-testing of a novel color indicator added to chlorine solutions used for decontamination of surfaces in Ebola Treatment Units. J Hosp Infect 2017 Nov 18. pii: S0195-6701(17)30628-X. doi: 10.1016/j.jhin.2017.11.004. [Epub ahead of print].
  • Keita AK, Toure A, Sow MS, Raoul H, Magassouba N, Delaporte E et al. Extraordinary long term and fluctuating persistence of Ebola virus RNA in semen of survivors in Guinea: implications for public health. Clin Microbiol Infect 2016 Nov 17. pii: S1198-743X(16)30560-2. doi: 10.1016/j.cmi.2016.11.005. [Epub ahead of print].
  • Keita M, Duraffour S, Loman NJ, Rambaut A, Diallo B, Magassouba N et al. Unusual Ebola virus chain of transmission, Conakry, Guinea, 2014-2015. Emerg Infect Dis 2016 Dec;22(12):2149-2152. doi: 10.3201/eid2212.160847.
  • Keita MM, Taverne B, Savané SS, March L, Doukoure M, Sow MS et al. Depressive symptoms among survivors of Ebola virus disease in Conakry (Guinea): preliminary results of the PostEboGui cohort. BMC Psychiatry 2017;17:127.
  • Keïta M, Conté F, Diallo B, Lufwa D, Katomba J, Snacken R et al. Lessons learned by surveillance during the tail-end of the Ebola outbreak in Guinea, June-October 2015: a case series. BMC Infectious Diseases 2017;17:304. doi 10.1186/s12879-017-2405-x.
  • Kerber R, Krumkamp R, Diallo B, Jaeger A, Rudolf M, Lanini S, et al. Analysis of diagnostic findings from the European Mobile Laboratory in Guéckédou, Guinea, march 2014 through march 2015. J Infect Dis 2016 Sep 16. pii: jiw269. [Epub ahead of print].
  • Kirigia JM, Masiye F, Kirigia DG, Akweongo P. Indirect costs associated with deaths from the Ebola virus disease in West Africa. Infect Dis Poverty 2015 Oct 29;4:45.
  • Kmietowicz Z. Ebola transmission ends in Guinea. BMJ 2015 Dec 29;351:h7014. doi: 10.1136/bmj.h7014.
  • Konde MK, Baker DP, Traore FA, Sow MS, Camara A, Barry AA et al. Interferon β-1a for the treatment of Ebola virus disease: A historically controlled, singlearm proof-of-concept trial. PLoS ONE 2017;12(2): e0169255. doi:10.1371/ journal.pone.0169255.
  • Kondé MK, Diop MK, Curtis MY, Barry A, Kouyaté S, Ghilardi L et al. Sex practices and awareness of Ebola virus disease among male survivors and their partners in Guinea. BMJ Glob Health 2017 Sep 25;2(3):e000412. doi: 10.1136/bmjgh-2017-000412. eCollection 2017.
  • Kpanake L, Gossou K, Sorum PC, Mullet E. Misconceptions about Ebola virus disease among lay people in Guinea: Lessons for community education. J Public Health Policy 2016 Feb 11. doi: 10.1057/jphp.2016.1.
  • Kramer AM, Pulliam JT, Alexander LW, Park AW, Rohani P,Drake JM. Spatial spread of the West Africa Ebola epidemic. R Soc Open Sci 2016 Aug 3;3(8):160294. eCollection 2016.
  • Krauer F, Gsteiger S, Low N, Hansen CH, Althaus CL. Heterogeneity in district-level transmission of Ebola virus disease during the 2013-2015 epidemic in West Africa. PLoS Negl Trop Dis 2016 Jul 19;10(7):e0004867. doi: 10.1371/journal.pntd.0004867. eCollection 2016.
  • Krause PR. Interim results from a phase 3 Ebola vaccine study in Guinea. TheLancet.com 2015;386:831-33.
  • Kucharski AJ, Eggo RM, Watson CH, Camacho A, Funk S, Edmunds WJ. Effectiveness of ring vaccination as control strategy for Ebola virus disease. Emerg Infect Dis 2016 Jan;22:105-8.
  • Kuhn JH, Andersen KG, Baize S et al. Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses 2014; 6:4760-99
  • Kurosaki Y, Magassouba N, Oloniniyi OK, Cherif MS, Sakabe S, Takada A et al. Development and Evaluation of Reverse Transcription-Loop-Mediated Isothermal Amplification (RT-LAMP) Assay Coupled with a Portable Device for Rapid Diagnosis of Ebola Virus Disease in Guinea. PLoS Negl Trop Dis 2016 Feb 22;10(2):e0004472. doi: 10.1371/journal .pntd.0004472. eCollection 2016.
  • Kurosaki Y, Magassouba N, Bah HA, Soropogui B, Doré A, Kourouma F et al. Deployment of a Reverse Transcription Loop-Mediated Isothermal Amplification Test for Ebola Virus Surveillance in Remote Areas in Guinea. J Infect Dis 2016 Aug 1. pii: jiw255. [Epub ahead of print].
  • Ladner JT, Wiley MR, Mate S, Dudas G, Prieto K, Lovett S et al. Evolution and Spread of Ebola Virus in Liberia, 2014-2015. Cell Host Microbe 2015;18:659-69.
  • Lambe T, Bowyer G, Ewer KJ. A review of Phase I trials of Ebola virus vaccines: what can we learn from the race to develop novel vaccines? Phil Trans R Soc B 2017;372:20160295.
  • Lamontagne F, Fowler RA, Adhikari NK, Murthy S, Brett-Major DM, Jacobs M et al. Evidence-based guidelines for supportive care of patients with Ebola virus disease. Lancet 2017 Oct 17. pii: S0140-6736(17)31795-6. doi: 10.1016/S0140-6736(17)31795-6. [Epub ahead of print].
    Editorial Lancet. Ebola PHEIC is over but emergency continues. The Lancet Infectious diseases 2016;16:507.
  • Landry Faye S. L’« exceptionnalité » d’Ébola et les « réticences » populaires en Guinée-Conakry. Réflexions à partir d’une approche d’anthropologie symétrique. Anthropologie & Santé [En ligne] 2015;mis en ligne le 30 novembre 2015. URL : http://anthropologiesante.revues.org/1796. doi: 10.4000/anthropologiesante.1796.
  • Le Marcis F. Traiter les corps comme des fagots ». Production sociale de l’indifférence en contexte Ebola (Guinée). Anthropologie & Santé [En ligne] 2015 : mis en ligne le 29 novembre 2015. URL : http://anthropologiesante. revues.org/1907. doi: 10.4000/anthropologiesante.1907.
  • Leander RN, Goff WS, Murphy CW, Pulido SA. Modelling Ebola within a community. Epidemiol Infect 2016;28:1-9.
  • Lee CT, Bulterys M, Martel LD, Dahl BA. Evaluation of a National Call Center and a Local Alerts System for Detection of New Cases of Ebola Virus Disease - Guinea, 2014–2015. MMWR 2016;65:227-30.
  • Lee H & Nishiura H.  Recrudescence of Ebola virus disease outbreak in West Africa, 2014–2016. IJID 2017 Sep 20. http://dx.doi.org/10.1016/j.ijid.2017.09.013.
  • Leligdowicz A, Fischer WA, Uyeki TM, Fletcher TE, Adhikari NK, Portella G et al. Ebola virus disease and critical illness. Crit Care 2016 Jul 29;20(1):217.
  • Leport C, Coignard H, Diehl JL. Organizing the French response to the Ebola virus infection in West Africa – ethical considerations on information given to patients, their relatives, and healthcare professionals. Med Mal Infect 2015 Apr;45(4):109-10.
  • Leuenberger D, Hebelamou J, Strahm S, De Rekeneire N, Balestre E, Wandeler G et al. Impact of the Ebola epidemic on general and HIV care in Macenta, Forest Guinea, 2014. AIDS 2015;29:1883-7.
  • Lewis H, Chaudry A, Ndow G, Crossey MM, Garside D, Njie R et al. Ebola: is the response justified? Pan Afr Med J 2015;22 (S1):23. Published online 2015 Oct 11. doi: 10.11694/pamj.supp.2015.22.1.6598. eCollection 2015.
  • Li Z, Teng Z, Feng X, Li Y, Zhang H. Dynamical Analysis of an SEIT Epidemic Model with Application to Ebola Virus Transmission in Guinea. Comput Math Methods Med 2015. doi: 10.1155/2015/582625. Epub 2015 Jul 2.
  • Lindblade KA, Nyenswah T, Keita S, Diallo B, Kateh F, Amoah A et al. Secondary Infections with Ebola Virus in Rural Communities, Liberia and Guinea, 2014-2015. Emerg Infect Dis 2016 Sep 15;22(9):1653-55. doi: 10.3201/eid2209.160416. [Epub ahead of print] ; Appendix technique (3 pages).
  • Liu W, Tang S & Xiao Y. Model Selection and Evaluation Based on Emerging Infectious Disease Data Sets including A/H1N1 and Ebola. Computational and Mathematical Methods in Medicine 2015;Article ID 207105,14 pages. http://dx.doi.org/10.1155/2015/207105.
  • Liu X, Speranza E, Muñoz-Fontela C, Haldenby S, Rickett NY, Garcia-Dorival I et al. Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus. Genome Biology 2017;18:4. doi: 10.1186/s13059-016-1137-3.
  • Lo TQ, Marston BJ, Dahl BA, De Cock KM. Ebola: Anatomy of an Epidemic. Annu Rev Med 2017;68:29.1-29.12.
  • Longuet C, Salam A, Dunning J. Recherche sur Ebola : une rencontre entre science et humanitaire. Alternatives humanitaires 2016;1:81-93.
  • Loubet P, Palich R, Kojan R, Peyrouset O, Danel C, Nicholas S et al. Development of a prediction model for Ebola virus disease: a retrospective study in Nzérékoré Ebola treatment center, Guinea. Am J Trop Med Hyg 2016;95(6):1362-67.
  • Loungou S. L’épidémie d’Ebola en Afrique de l’Ouest. L'Espace Politique 2015;26, mis en ligne le 26 juillet 2015. http://www.espacepolitique.revues.org/3467
  • Lucinski MM, Guilavogui T, Sidikiba S, Diakité N, Diakité S, Dioubaté M et al. Effect of the Ebola-virus-disease epidemic on malaria case management in Guinea, 2014: a cross-sectional survey of health facilities. Lancet Infect Dis Published online June 24, 2015, http://dx.doi.org/10.1016/S1473-3099(15)00061-4/
  • Lüdtke A, Ruibal P, Becker-Ziaja B, Rottstegge M, Wozniak DM, Cabeza-Cabrerizo M. Ebola virus disease is characterized by poor activation and reduced levels of circulating CD16+ monocytes. J Infect Dis 2016 Aug 11. pii: jiw260. [Epub ahead of print].
  • Madec S, Valade E. Transport aérien de patients hautement contagieux : expérience de la maladie à virus Ebola. Médecine et Armées 2016;44:121-26.
  • Maehira Y, Kurosaki Y, Saito T, Yasuda J, Tarui M, Malvy DJM et al. Responding to ever-changing epidemiological dynamics of Ebola virus disease. BMJ Glob Health 2016 Nov 24;1(3):e000180. doi: 10.1136/bmjgh-2016-000180. eCollection 2016 Nov.
  • Magro L, Jacquelin B, Escadafal C, Garneret P, Kwasiborski A, Manuguerra JC et al. Paper-based RNA detection and multiplexed analysis for Ebola virus diagnostics. Sci Rep 2017 May 2;7(1):1347. doi: 10.1038/s41598-017-00758-9.
  • Mailles A, Noel H, Pannetier D, Rapp C, Yazdanpanah Y, Vandentorren S et al. Strengthened Ebola surveillance in France during a major outbreak in West Africa: March 2014-January 2016. Epidemiol Infect 2017 Nov 23:1-13. doi: 10.1017/S0950268817002552. [Epub ahead of print].
  • Malvy D et le Groupe d’étude JIKI. Évaluation des antiviraux dans la maladie à virus Ébola, Guinée, 2014-2015 : Enjeux et perspectives. Séance dédiée : « Les financements innovants en matière de santé et l’épidémie à virus Ébola ». Bull Acad Natle Méd 2014;198:1515-27
  • Malvy D. Produire de la science en situation de crise. Les traitements médicamenteux spécifiques dela maladie à virus Ébola en 2016 : leçons et perspectives. Bull Soc Pathol Exot 2016;109:262-71.
  • Malvy D. Éthique et recherche en situation de crise : l'exemple d'Ébola. Notes techniques AFD mai 2017;30:75-80.
  • Mamadou Mbaye E, Kone S, Kâ O, Mboup S. Évolution de l’implication des communautés dans la riposte à Ébola. Santé Publique 2017 Oct 2;29(4):487-496. doi:10.3917/spub.174.0487.
  • Manet G, Bédubourg G, de Laval F, Mayet A, Berger F, Dia A et al. Epidémie de maladie à virus Ebola en Guinée Conakry : suivi du personnel militaire de retour de mission au Centre de traitement des soignants de mars à octobre 2015. Médecine et Armées 2016;44:197-202.
  • Manet G, Bédubourg G, Velut G, de Laval F, Mayet A, Dia A et al. Monitoring of returneesfromEbola-affected areas: lessons learned based on the experience of French armed forcesdeployed in Guinea, 2015. J Public Health (Oxf) 2017 Aug 31:1-7. doi: 10.1093/pubmed/fdx107.
  • Marcon S, Filhos N. Guinée : les infirmiers militaires au chevet des soignants atteints d’Ébola. Rev Infirm 2015 Nov;64(215):33-7.
  • Marston BJ, Dokubo EK, van Steelandt A, Martel L, Williams D, Hersey S et al. Ebola Response Impact on Public Health Programs, West Africa, 2014-2017. Emerg Infect Dis 2017 Dec;23(13). doi: 10.3201/eid2313.170727.
  • Martin B. Épidémies : ce qu’Ebola nous dit. Introduction. Humanitaire 2015;40:11.
  • Maugey N, Mérens A, Quentin B, Valade E, Boutin HP, Conte B et al. Conception, déploiement, architecture et fonctionnement du Centre de traitement des soignants. Médecine et Armées 2016;44:161-7.
  • McNamara LA, Schafer IJ, Nolen LD, MD, Gorina Y, Redd JT, Lo T et al. Ebola Surveillance — Guinea, Liberia, and Sierra Leone. MMWR 2016;65(3):35-43.
  • Meltzer MI, Santibanez S, Fischer LS, Merlin TL, Adhikari BB, Atkins CY et al. Modeling in real time during the Ebola response. MMWR 2016;65(3):85-9.
  • Mendoza EJ, Qiu X, Kobinger GP. Progression of Ebola Therapeutics During the 2014-2015 Outbreak. Trends Mol Med 2016 Jan 13. pii: S1471-4914(15)00235-X. doi: 10.1016/j.molmed.2015.12.005. [Epub ahead of print].
  • Mérens A, Bigaillon C, Delaune D. Maladie à virus Ébola : évolution 2014–2017 de la biologie et du diagnostic. Med Mal Infect 2017 8 décembre. Doi : 10.1016/j.medmal.2017.11.002. [Epub ahead of print].
  • Merler S, Ajelli M, Fumanelli L, Parlamento S, Pastore y Piontti A, Dean NE et al. Containing Ebola at the Source with Ring Vaccination. PLOS Neglected Tropical Diseases 2016. DOI:10.1371/journal.pntd.0005093 November 2, 2016.
  • Merrill RD, Ward SE, Oppert MC, Schneider DA. From one to the other: responding to Ebola cases on either side of the line. Pan Afr Med J 2017 May 28;27(Suppl 1):12. doi: 10.11604/pamj.supp.2017.27.1.12568. eCollection 2017.
  • Migliani R, Keita S, Diallo B, Rodier G, Perea W, Dahl B. Maladie à virus Ebola en Guinée : évolution de l’épidémie de son émergence en décembre 2013 à novembre 2015. Médecine et Armées 2016;44:149-60.
  • Migliani R, Keïta S, Diallo B, Mesfin S, Perea W, Dahl B et al. Aspects épidémiologiques de la maladie à virus Ébola en Guinée (décembre 2013-avril 2016). Bull Soc Pathol Exot 2016;109:218-35.
  • Migliani R. Épidémie d’Ébola, 2013-2016. Notes techniques AFD mai 2017;30:64-8.
  • Moisan F, Traore A, Zoumanigui D, Feindouno JY, Sagno AM, Mollet T et al. Public health structures attendance during the Ebola outbreak in Guéckédou, Guinea. Epidemiol Infect 2016 Apr 18:1-7.
  • Moreau M, Spencer C, Gozalbes JG, Colebunders R, Lefevre A, Gryseels S et al. Lactating mothers infected with Ebola virus: EBOV RT-PCR of blood only may be insufficient. Eurosurveillance 2015;20:22 January 2015.
  • Moulin AM. L’anthropologie au défi de l’Ebola. Anthropologie & Santé [En ligne] 2015, mis en ligne le 30 novembre 2015. URL : http://anthropologiesante.revues.org/1954. doi: 10.4000/anthropologiesante.1954.
  • Moulin AM. « Back to the Future ». Les essais vaccinaux contre Ébola, au regard de l’histoire des résistances à l’immunisation. Bull Soc Pathol Exot 2016;109:287-95.
    Moulin AM. Sur les traces des épidémies d’Ébola pour éviter leur retour. Dossier : Épidémie d’Ébola : Quels enseignements ? Tribunes. adsp mars 2017;98:50-1.
  • Msellati P, Touré A, Sow MS, Cécé K, Taverne B,·Desclaux A et al. (Re)vivre après Ebola : bilan à un an et perspectives d’une étude d’évaluation et accompagnement des patients déclarés guéris d’une infection par le virus Ébola en Guinée (cohorte PostEboGui). Bull Soc Pathol Exot 2016;109:236-43.
  • Nadhem S, Nejib HD. The Ebola contagion and forecasting virus: evidence from four African countries. Health Econ Rev 2015; 5: 16.
  • Naidoo D, Durski K, Formenty P. Réponse des laboratoires à l’épidémie d’Ebola en Afrique de l’Ouest, 2014 2015. Relevé Epidémiologique Hebdomadaire OMS 2015;32:393-96.
  • Nau JY. Pourquoi le virus Ebola (qui sévit aujourd’hui en Guinée) ne nous effraie-t-il pas ? Rev Med Suisse 2014:10;834-35
  • Nau JY. L’OMS est-elle coupable d’avoir tardé dans la lutte contre Ébola ? Rev Med Suisse 2014;10:1634-35.
  • Nau JY. Ébola : vaccin à marche forcée. Espoirs pour le Zmapp. Rev Med Suisse 2014;10:1682-83.
  • Nau JY. L’épidémie Ébola, miroir de l’impuissance onusienne ? Rev Med Suisse 2014;10:1684-85.
    Nau JY. « Ébola : une crise humanitaire majeure qui va durer» (Pr Peter Piot) Rev Med Suisse 2014;10:1892-93.
  • Nau JY. Petit bréviaire pour qu’Ebola ne prenne pas la voie des airs. Rev Med Suisse 2014;10:2068-69.
  • Nau JY. Ébola ou le souvenir paradoxal de la médecine coloniale. Rev Med Suisse 2014;10:2176-76.
  • Nau JY. Ebola : trois essais cliniques expérimentaux sous l’égide de MSF. Rev Med Suisse 2014;10:2292-93.
  • Nau JY. Ébola : au sujet de quelques occasions ratées de la France en Guinée. Rev Med Suisse 2014;10:2342-43.
  • Nau JY. Ébola : la note de MSF sur la situation épidémiologique dans l’ouest de l’Afrique. Rev Med Suisse 2014;10:2436-37.
  • Nau JY. Ébola restera d’actualité tout au long de l’année 2015. Rev Med Suisse 2015;11;162-63.
  • Nau JY. Ébola et favipiravir : quand le politique préempte la communication scientifique. Rev Med Suisse 2015;11:574-75.
  • Nau JY. Ébola : les accusations de MSF, le silence de l’OMS. Rev Med Suisse 2015:11;834-35.
  • Nau JY. Août 2015 : les premiers résultats vaccinaux encourageants contre Ébola. Rev Med Suisse 2015;11:1508-09.
  • Nau JY. Première offensive internationale d’envergure pour vacciner contre Ébola. Rev Med Suisse 2017;13:924-25.
  • Ndawinz JDA, Cissé M, Diallo MSK, Sidibé CT, D’Ortenzio E. Prevention of HIV spread during the Ebola outbreak in Guinea. Lancet 2015;385,April 11,1393
  • Nguyen THT, Guedj J, Anglaret X, Laouénan C, Madelain V, Taburet AM et al. Favipiravir pharmacokinetics in Ebola-infected patients of the JIKI trial reveals concentrations lower than targeted. PLoS Negl Trop Dis 2017;11(2):e0005389. doi:10.1371/journal.pntd.0005389.
  • Nohrstedt D, Baekkeskov E. Political drivers of epidemic response: foreign healthcare workers and the 2014 Ebola outbreak. Disasters 2017 Apr 25. doi: 10.1111/disa.12238. [Epub ahead of print].
  • Nordenstedt H, Bah EI, de la Vega MA, Barry M, N'Faly M et al. Ebola Virus in Breast Milk in an Ebola Virus-Positive Mother with Twin Babies, Guinea, 2015. Emerg Infect Dis 2016 Apr;22(4):759-60.
  • Omilabu SA, Salu OB, Oke BO, James AB. The West African ebola virus disease epidemic 2014-2015: A commissioned review. Niger Postgrad Med J 2016 Apr-Jun;23(2):49-56.
  • Omoleke SA, Ibrahim Mohammed I, and Saidu Y. Ebola Viral Disease in West Africa: A Threat to Global Health, Economy and Political Stability. J Public Health Africa 2016 Aug 17; 7(1): 534. 
  • Published online 2016 Aug 17. doi:  10.4081/jphia.2016.534.
  • Ortuno-Gutierrez N, Zachariah R, Woldeyohannes D. Upholding Tuberculosis Services during the 2014 Ebola Storm: An Encouraging Experience from Conakry, Guinea. PLoS One 2016 Aug 17;11(8):e0157296. doi: 10.1371/ journal.pone.0157296. eCollection 2016.
  • Pagano H, Poncin M. Treating, Containing, Mobilizing. The role of Médecins Sans Frontières in the West African Ebola epidemic response. In : "Global management of infectious disease after Ebola", édité par Halabi S.F. et al. Oxford University Press 2016;Chap. 3:33-53.
  • Palich R, Gala JL, Petitjean F, Shepherd S, Peyrouset O, Abdoul BM et al. A 6-Year-Old Child with Severe Ebola Virus Disease: Laboratory-Guided Clinical Care in an Ebola Treatment Center in Guinea. PLoS Negl Trop Dis 2016 Mar 24;10(3):e0004393. doi: 10.1371/journal.pntd.0004393. eCollection 2016.
  • Palich R, Irenge LM, Barte de Sainte Fare E, Augier A, Malvy D et al. Ebola virus RNA detection on fomites in close proximity to confirmed Ebola patients; N'Zerekore, Guinea, 2015. PLoS One 2017 May 11;12(5):e0177350. doi: 10.1371/journal.pone.0177350.
  • Parpia AS, Ndeffo-Mbah ML, Wenzel NS, Galvani AP. Effects of Response to 2014-2015 Ebola Outbreak on Deaths from Malaria, HIV/AIDS, and Tuberculosis, West Africa. Emerg Infect Dis 2016 Mar;22(3):433-41.
  • Patterson DA. Le virus Ebola : un révélateur d’inégalités biomédicales et une intervention internationale hétérogène. Anthropologie & Santé [En ligne] 2015 ; mis en ligne le 11 décembre 2015. URL : http://anthropologiesante. revues.org/1914. doi: 10.4000/anthropologiesante.1914.
  • Peak CM, Childs LM, Grad YH, Buckee CO. Comparing nonpharmaceutical interventions for containing emerging epidemics. PNAS 2017 April 11;114:4023-28.
  • Perry HB, Dhillon RS, Liu A, Chitnis K, Panjabi R, Palazuelos D et al. Community health worker programmes after the 2013–2016 Ebola outbreak. Bull World Health Organ 2016 Jul 1; 94(7): 551–53.
  • Pers YM, Sow MS, Taverne B, March L, Izard S, Étard JF et al. Characteristics of the musculoskeletal symptoms observed among survivors of Ebola virus disease in the Postebogui cohort in Guinea. Rheumatology (Oxford) 2017 Mar 22. doi: 10.1093/rheumatology/kex074.
  • Petti S, Messano GA, Vingolo EM, Marsella LT, Scully C. The face of Ebola: changing frequency of haemorrhage in the West African compared with Eastern-Central African outbreaks. BMC Infect Dis 2015;15:564.
  • Peiffer-Smadja N, Ouedraogo R, D'Ortenzio E, Cissé PN, Zeggani Z, Beavogui AH et al. Vaccination and blood sampling acceptability during Ramadan fasting month: A cross-sectional study in Conakry, Guinea. Vaccine 2017 May 2;35(19):2569-2574.
  • Pigott DM, Golding N, Mylne A, Huang Z, Henry AJ, Brady OJ et al. Mapping the zoonotic niche of Ebola virus disease in Africa. eLife 2014;3: e04395. DOI: 107554/eLife.04395
  • Pigott DM, Millear AI, Earl L, Morozoff C, Han BA, Shearer FM, Weiss DJ et al. Updates to the zoonotic niche map of Ebola virus disease in Africa. eLife 2016;5:e16412. DOI: 10.7554/eLife.16412.
  • Pigott DM, Deshpande A, Letourneau I, Morozoff C, Reiner RC Jr, Kraemer MUG et al. Local, national, and regional viral haemorrhagic fever pandemic potential in Africa: a multistage analysis. Lancet 2017 Oct 11. pii: S0140-6736(17)32092-5. doi: 10.1016/S0140-6736(17)32092-5. [Epub ahead of print].
  • Piot P, Blanchet K. "Tout le monde a commencé beaucoup trop tard du fait d’un déni généralisé…". Humanitaire 2015;40:64-67.
  • Poncin M. A la rencontre des autorités nationales : l’expérience guinéenne de Médecins Sans Frontières pendant l’épidémie d’Ebola. Alternatives huanitaires 2016;3:28-39.
  • PREVAIL II Writing Group; Multi-National PREVAIL II Study Team. A randomized, controlled trial of ZMapp for Ebola virus infection. N Engl J Med 2016 Oct 13;375(15):1448-1456.
  • Proschan MA, Dodd LE, Price D. Statistical considerations for a trial of Ebola virus disease therapeutics. Clin Trials 2016 Jan 14. pii: 1740774515620145. [Epub ahead of print].
  • Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E, Cowley L, Real-time, portable genome sequencing for Ebola surveillance. Nature 2016 Feb 3. doi: 10.1038/nature16996. [Epub ahead of print].
  • Qureschi AI, Chughtai M. Acute specialized care of patients with Ebola virus disease: gaps and opportunities. JVNI 2015;8:S1-3.
  • Qureschi AI, Chughtai M, Bah EI, Barry M, Béavogui K, Loua TO et al. High survival rates and associated factors among Ebola virus disease patients hospitalized at Donka national hospital, Conakry, Guinea. JVNI 2015;8:S4-11.
  • Qureschi AI, Chughtai M, Loua TO, Pe Kolie J, Camara HF, Ishfaq MF et al. Study of Ebola Virus Disease Survivors in Guinea. Clin Infect Dis 2015 Jun 9. pii: civ453. [Epub ahead of print].
  • Rabaud C, Merens C, Blanchard H, Amprou AC. Evaluation de l’état de préparation des établissements de santé de référence habilités. Dossier : Épidémie d’Ébola : Quels enseignements ? Les prises en charge dans les pays du Nord. adsp mars 2017;98:32-5.
  • Rainisch G, Shankar MB, Wellman M, Merlin TL, Meltzer MI. Regional Spread of Ebola Virus, West Africa, 2014. Emerg Infect Dis 2015 March;21(2):444-47.
  • Ramade S, Moroge S, Delahaye A, Dampierre H, Carmoi T, Ficko C et al. Prise en compte des aspects psychologiques et transculturels des patients atteints ou suspects de maladie à virus Ebola admis au Centre de traitement des soignants de Conakry (Guinée) janvier-juillet 2015. Médecine et Armées 2016;44:187-96.
  • Rapp C. Epidémie à virus Ébola en Afrique de l’Ouest : réalités et perspectives. Med Sante Trop 2014 Jul-Sep;24(3):229-31
  • Rapp C, Merens A. Interventions du service de santé des armées dans la gestion de l’épidémie. Dossier : Épidémie d’Ébola : Quels enseignements ? Tribunes. adsp mars 2017;98:44-6.
  • Reques L, Bolibar I, Chazelle E, Gomes L, Prikazsky V, Banza et al. Evaluation of contact tracing activities during the Ebola virus disease outbreak in Guinea, 2015. Int Health 2017 Mar 1;9(2):131-133. doi: 10.1093/inthealth/ihx004.
  • Reynard O, Volchkov V, Peyrefitte C. Une première épidémie de fièvre à virus Ebola en Afrique de l’Ouest. Médecine/Sciences 2014;30:671-3
  • Rico A, Brody D, Coronado F, Rondy M, Fiebig L, Carcelen A et al. Epidemiology of epidemic Ebola virus disease in Conakry and surrounding prefectures, Guinea, 2014–2015. Emerging Infectious Diseases 2016;22:178-83.
  • Rivera A, Messaoudi I. Molecular mechanisms of Ebola pathogenesis. J Leukoc Biol 2016 Nov;100(5):889-904. Epub 2016 Sep 1.
  • Røttingen JA. Ebola vaccine trial in Guinea. TheLancet.com 2015;385:2459-60.
  • Rouse EN, Zarecki SM, Flowers D, Robinson ST, Sheridan RJ, Goolsby GD et al. Safe and effective deployment of personnel to support the Ebola response — West Africa. MMWR 2016;65(3):90-7.
  • Ruibal P, Oestereich L, Lüdtke A et al. Unique human immune signature of Ebola virus disease in Guinea. Nature 2016 May 5;533(7601):100-4.
  • Rulli MC, Santini M, Hayman DTSD, Odorico P. The nexus between forest fragmentation in Africa and Ebola virus disease outbreaks. Sci Rep 2017 Feb 14;7:41613. doi: 10.1038/srep41613.
  • Sacks JA, Zehe E, Redick C, Bah A, Cowger K, Camara M, et al. Introduction of mobile health tools to support Ebola surveillance and contact tracing in Guinea. Glob Health Sci Pract 2015;3(4):646-659.
  • Saéz AM, Weiss S, Nowak K, Lapeyre V, Zimmermann F, Düx A et al. Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Mol Med 2015;7:17–23.
  • Sagui E, Janvier F, Baize S, Foissaud V, Koulibaly F, Savini H et al. Severe Ebola virus infection with encephalopathy. Evidence for direct virus involvement. Clin Infect Dis. 2015 Jul 21. pii: civ606. [Epub ahead of print].
  • Salignon P, Absolu A. L’action de l’État français en Guinée : envers et par-delà Ebola. Humanitaire 2015;40:52-63.
  • Sams K, Desclaux A, Anoko J, Akindès F, Egrot M, Sow K, Taverne B, Bila B, Cros M, Diop M, Fribault M, for the Réseau Ouest Africain Anthropologie des Epidémies Emergentes and Wilkinson A for the Social Science in Humanitarian Action Platform. Mobilising experience from Ebola to address plague in Madagascar and future epidemics. The Lancet, Nov 28 2017, http://dx.doi.org/10.1016/S0140-6736(17)33088-X.
  • Sams K, Desclaux A. From Ebola to Plague and Beyond: How Can Anthropologists Best Engage Past Experience to Prepare for New Epidemics? Dispatches, Cultural Anthropology website, December 7, 2017. https://culanth.org/fieldsights/1256-from-ebola-to-plague-and-beyond-how-can-anthropologists-best-engage-past-experience-to-prepare-for-new-epidemics.
  • Santermans E, Robesyn E, Ganyani T, Sudre B, Faes C, Quinten C et al. Spatiotemporal Evolution of Ebola Virus Disease at Sub-National Level during the 2014 West Africa Epidemic: Model Scrutiny and Data Meagreness. PLoS One 2016 Jan 15;11(1):e0147172. doi: 10.1371/journal.pone.0147172.
  • Saurabh S, Prateek S. Role of contact tracing in containing the 2014 Ebola outbreak: a review. Afr Health Sci 2017 Mar;17(1):225-236. doi: 10.4314/ahs.v17i1.28.
  • Savini H,·Maugey N, Aletti M,·Facon A,·Koulibaly F,·Cotte J et al. Prise en charge globale du patient contaminé par le virus Ébola, expérience du Centre de traitement des soignants de Conakry, Guinée. Bull Soc Pathol Exot 2016;109:281-86.
  • Savini H, Janvier F, Karkowski L, Billhot M, Aletti M, Bordes J et al. Occupational exposures to Ebola virus in Ebola Treatment Center, Conakry, Guinea. Emerg Infect Dis 2017 Aug;23(8):1380-1383. doi: 10.3201/eid2308.161804.
  • Schafer IJ, Knudsen E, McNamara LA, Agnihotri S, Rollin PE, Islam A. The Epi Info Viral Hemorrhagic Fever (VHF) application: a resource for outbreak data management and contact tracing in the 2014-2016 West Africa Ebola epidemic. J Infect Dis 2016 Sep 1. pii: jiw272. [Epub ahead of print].
  • Scott V, Crawford-Browne S, Sanders D. Critiquing the response to the Ebola epidemic through a Primary Health Care Approach. BMC Public Health 2016;16:410. doi: 10.1186/s12889-016-3071-4.
  • Sealy TK, Erickson BR, Taboy CH, Ströher U, Towner JS, Andrews SE et al. Laboratory Response to Ebola — West Africa and United States. MMWR 2016;65(3):44-9.
  • Seytre B. Time to change Ebola communication. African Affairs, 2015 Nov 19, http://afraf.oxford journals.org/letters/114/454/136#123.
  • Seytre B. Les errances de la communication sur la maladie à virus Ébola. Bull Soc Pathol Exot 2016;109:314-23.
  • Shen M, Xiao Y, Rong L. Modeling the effect of comprehensive interventions on Ebola virus transmission. Sci Rep 2015 Oct 30;5:15818. doi: 10.1038/srep15818.
  • Shoman H, Karafillakis E, Rawaf S. The link between the West African Ebola outbreak and health systems in Guinea, Liberia and Sierra Leone: a systematic review. Global Health 2017 Jan 4;13(1):1. doi: 10.1186/s12992-016-0224-2.
  • Shuchman M. Ebola vaccine trials in West Africa faces criticism. The Lancet.com 2015;385:1933-34.
  • Shultz JM, Espinel Z, Espinola M, Rechkemmer A. Distinguishing epidemiological features of the 2013–2016 West Africa Ebola virus disease outbreak. Disaster Health 2016;3(3):1-11. http://dx.doi.org/10.1080/21665044.2016. 1228326.
  • Simon-Loriere E, Faye O, Faye O, Koivogui L, Magassouba N, Keita S et al. Distinct lineages of Ebola virus in Guinea during the 2014 West African epidemic. Nature 2015;524:102–104.
  • Simon-Lorière H, Lysaniuk B, La diffusion d’Ébola dans les pays de la Mano River : approche géographique. EchoGéo 2015. URL : http://echogeo.revues.org/14096 ; doi: 10.4000/echogeo.14096.
  • Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S et al. Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea. PLoS Med 2016 Mar 1;13(3):e1001967. [erratum : PloS Med. DOI:10.1371/journal.pmed.1002009. April 5, 2016], [erratum : PloS Med. doi:10.1371/journal.pmed.1002066 June 10, 2016].
  • Sissoko D, Keïta M, Diallo B, Aliabadi N, FitterDL, Dahl BA et al. Ebola virus persistence in breast milk after no reported illness: a likely source of virus transmission from mother to child. Clinical Infectious Diseases 2016 Dec 10.Advance Access published.
  • Sissoko D, Duraffour S, Kerber R, Kolie JS, Beavogui AH, Camara AM et al. Persistence and clearance of Ebola virus RNA from seminal fluid of Ebola virus disease survivors: a longitudinal analysis and modelling study. Lancet Glob Health 2017 Jan;5(1):e80-e88. doi: 10.1016/S2214-109X(16)30243-1.
  • Sow MS, Etard JF, Baize S, Magassouba N, Faye O, Msellati P et al. New Evidence of Long-lasting Persistence of Ebola Virus Genetic Material in Semen of Survivors. J Infect Dis 2016 May 3. pii: jiw078.
  • Sow S, Desclaux A, Taverne B & Groupe d’étude PostEboGui. Ébola en Guinée : formes de la stigmatisation des acteurs de santé survivants. Bull Soc Pathol Exot 2016;109:309-13.
  • Spengler JR, Ervin ED, Towner JS, Rollin PE, Nichol ST. Perspectives on West Africa Ebola Virus Disease Outbreak, 2013–2016. Emerg Infect Dis 2016;22:956-63.
  • Steptoe PJ, Scott JT, Harding SP, Beare NAV, Semple MG, Vandy MJ et al. Ocular Complications in survivors of the Ebola outbreak in Guinea. Am J Ophthalmol 2017 Jul 28. pii: S0002-9394(17)30288-X. doi: 10.1016/j.ajo. 2017.05.029.
  • Subtil F, Delaunay C, Keita AK, Sow M, Touré AI, Leroy S et al. Dynamics of Ebola RNA persistence in semen: report from the Postebogui cohort in Guinea. Clin Infect Dis 2017 Jun 15;64(12):1788-1790. doi: 10.1093/cid/cix210.
  • Suk JE, Paez Jimenez A, Kourouma M, Derrough T, Baldé M, Honomou P et al. Post-Ebola Measles Outbreak in Lola, Guinea, January-June 2015(1). Emerg Infect Dis 2016 Jun;22(6):1106-8. doi: 10.3201/eid2206.151652.
  • Taylor BP, Dushoff J, Weitz JS. Stochasticity and the limits to confidence when estimating R0 of Ebola and other emerging infectious diseases. J Theor Biol 2016 Aug 11. pii: S0022-5193(16)30246-6. doi: 10.1016/j.jtbi.2016.08.016. [Epub ahead of print].
  • Thiam S, Delamou A, Camara S, Carter J, Lama EK, Ndiaye B et al. Challenges in controlling the Ebola outbreak in two prefectures in Guinea: why did communities continue to resist? Pan Afr Med J 2015;22 (S1):22. Published online 2015 Oct 11.doi: 10.11694/pamj.supp.2015.22.1.6626. eCollection 2015.
  • Thys S, Boelaert M. Sur l’origine d’Ébola : discours biomédical versus interprétations populaires à Macenta en Guinée. Santé Publique 2017 Oct 2;29(4):497-507. doi:10.3917/spub.174.0497.
  • Tiffany A, Moundekeno FP, Traoré A, Haile M, Sterk E, Guilavogui T et al. Community-based surveillance to monitor mortality in a malaria-endemic and Ebola-epidemic setting in rural Guinea. Am J Trop Med Hyg 2016 Oct 3. pii: 16-0376 [Epub ahead of print].
  • Tiffany A, Dalziel BD, Kagume Njenge H, Johnson G, Nugba Ballah R, James D et al. Estimating the number of secondary Ebola cases resulting from an unsafe  burial and risk fctors for transmission during the West Africa Ebola epidemic. Plos Negl Trop Dis 2017;11(6):e0005491. Doi:10.1371/journal.pnt.0005491.
  • Touré A, Sow MS, Etard J, Keita A, Leroy S, Taverne B, Savane I, Barry M, Delaporte E, Groupe d’étude Postebogui: Séquelles liées au virus Ebola : résultats de la cohorte Postebogui. Médecine Mal Infect 2016;46(4 Suppl 1):18.
  • Travers S, Astud CE, Calamai F, Molé S, Bignand M, Tourtier JP. Transport pré-hospitalier de patients cas possibles ou confirmés de maladie à virus Ebola. Expérience de la Brigade des sapeurs-pompiers de Paris. Médecine et Armées 2016;44:127-33.
  • Undurraga EA, Carias C, Meltzer MI, Kahn EB. Potential for broad-scale transmission of Ebola virus disease during the West Africa crisis: lessons for the Global Health security agenda. Infect Dis Poverty 2017 Dec 1;6(1):159. doi: 10.1186/s40249-017-0373-4.
  • Uyeki TM, Mehta AK, Davey RT jr, Liddell AM, M.D., Wolf T et al. Clinical Management of Ebola Virus Disease in the United States and Europe. N Engl J Med 2016 Feb 18; 374(7): 636–646. doi: 10.1056/NEJMoa1504874
  • Valencia C, Bah H, Fatoumata B, Rodier G, Diallo B, Koné M et al. Network visualization for outbreak response; mapping the Ebola Virus Disease (EVD) chains of transmission in N'Zérékoré, Guinea. J Infect March 2017;74:294–301.
  • Valeri L, Patterson-Lomba O, Gurmu Y, Ablorh A, Bobb J, Townes FW, Harling G.Predicting subnational Ebola virus disease epidemic dynamics from sociodemographic indicators. PLoS One 2016 Oct 12;11(10):e0163544. doi: 10.1371/journal.pone.0163544. eCollection 2016.
  • Van Beneden CA, Pietz H, Kirkcaldy RD, Koonin LM, Uyeki TM, Oster AM et al. Early Identification and Prevention of the Spread of Ebola — United States. MMWR 2016;65(3):75-84.
  • Van Bortel T, Basnayake A, Wurie F, Jambai M, Koroma AS, Muana AT. Psychosocial effects of an Ebola outbreak at individual, community and international levels. Bull World Health Organ 2016 Mar 1;94(3):210-4.
  • Van den Bergh R, Chaillet P, Sow MS, Amand M, Charlotte van Vyve C, Jonckheere S et al. Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea. Emerging Infectious Diseases 2016;22:210-16.
  • Van Griensven J, De Weiggheleire A, Delamou A, Smith PG, Edwards T, Vandekerckhove P et al. The use of Ebola Convalescent Plasma to treat Ebola Virus Disease in resource constrained settings: A perspective from the field. Clin Infect Dis 2015 Aug 10. pii: civ680. [Epub ahead of print].
    van Griensven J, Edwards T, de Lamballerie X, Semple MG, Gallian P, et al. Evaluation of Convalescent Plasma for Ebola Virus Disease in Guinea. N Engl J Med 2016 Jan 7;374(1):33-42.
  • Van Griensven J, Bah EI, Haba N, Delamou A, Camara BS, Olivier KJ et al. Electrolyte and Metabolic disturbances in Ebola patients during a clinical trial, Guinea, 2015. Emerg Infect Dis 2016 Dec;22(12). doi: 10.3201/eid2212.161136.
  • Van Griensven J, Edwards T, Baize S, Ebola-Tx Consortium. Efficacy of convalescent plasma in relation to dose of Ebola virus antibodies. N Engl J Med 2016 Dec 8;375(23):2307-2309.
  • VanSteelandt A, Aho J, Franklin K, Likofata J, Kamgang JB, Keita S et al. Operational evaluation of rapid diagnostic testing for Ebola Virus Disease in Guinean laboratories. PLoS One 2017 Nov 30;12(11):e0188047. doi: 10.1371/journal.pone.0188047. eCollection 2017.
  • Vernet MA, Reynard S, Alexandra Fizet A, Schaeffer J, Pannetier D, Jeremie Guedj J et al. Clinical, virological, and biological parameters associated with outcomes of Ebola virus infection in Macenta, Guinea. JCI Insight 2017;2(6):e88864.
  • Victory KR, Coronado F, Ifono SO, Soropogui T, Dahl BA. Ebola transmission link to a single funeral ceremony, Kissidougou, Guinea, decembre 2014-janvier 2015. MMWR April 2015;64:386-88.
  • Victory KR, Coronado F, Ifono SO, Martel LD, Keita S, Dahl BA. Unsafe Burials: Challenge to Controlling Local Ebola Outbreaks in Guinea 2015-2016. J Epid Prev Med 2016 September 15;2(2):117.
  • Walker PGT, White MT, Griffin JT, Reynolds A, Ferguson NM, Ghani A. Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis. Lancet Infect Dis PApril 24, 2015, http://dx.doi.org/10.1016/S1473-3099(15)70124-6.
  • Webb G, Browne C, Huo X, Seydi O, Seydi M, Magal P. A Model of the 2014 Ebola Epidemic in West Africa with Contact Tracing. Plos Currents Outbreaks 2015 Jan 30 doi: 10.1371/currents.outbreaks.846b2a31ef37018b7d1126 a9c8adf22a.
  • Webb GF, Browne CJ. A model of the Ebola epidemics in West Africa incorporating age of infection. J Biol Dyn 2016 Dec;10:18-30.
  • WHO Ebola Response Team (2014).Ebola Virus Disease in West Africa. The First 9 Months of the Epidemic and Forward Projections. N Engl J Med 2014 Oct 16;371(16):1481-95.
  • Widdowson MA, Schrag SJ, Carter RJ, Carr W, Legardy-Williams J, Gibson L et al. Implementing an Ebola vaccine study — Sierra Leone. MMWR 2016;65(3):98-106.
  • Wilkinson A, Fairhead J. Comparison of social resistance to Ebola response in Sierra Leone and Guinea suggests explanations lie in political configurations not culture. Critical Public Health 2017;27:14-27.
  • Wiratsudakul A, Triampo W, Laosiritaworn Y, Modchang C. A one-year effective reproduction number of the 2014-2015 Ebola outbreaks in the widespread West African countries and quantitative evaluation of air travel restriction measure. Travel Med Infect Dis 2016 Sep - Oct;14(5):481-488. doi: 10.1016/j.tmaid.2016.06.011.
    Wölfel R, Stoecker K, Fleischmann E, Gramsamer B, Wagner M, Molkenthin P et al. Mobile diagnostics in outbreak response, not onlyfor Ebola: a blueprint for a modular and robust field laboratory. Euro Surveill 2015;20(44):31-39.
  • Wong ZS, Bui CM, Chughtai AA, Macintyre CR. A systematic review of early modelling studies of Ebola virus disease in West Africa. Epidemiol Infect 2017 Feb;7:1-26. doi: 10.1017/S0950268817000164. [Epub ahead of print]
  • Wong G, Mendoza EJ, Plummer FA, Gao GF, Kobinger GP, Qiu X. From bench to almost bedside: the long road to a licensed Ebola virus vaccine. Expert Opin Biol Ther 2017 Nov 17:1-15. doi: 10.1080/14712598.2018.1404572. [Epub ahead of print].
  • Yazdanpanah Y, Arribas JR, Malvy D. Treatment of Ebola virus disease. Intensive Care Med 2015;41:115-17.
  • Zachariah R, Ortuno N, Hermans V, Desalegn W, Rust S, Reid AJ et al. Ebola, fragile health systems and tuberculosis care: a call for preemptive action and operational research. Int J Tuberc Lung Dis 2015;19(11):1271–1275
  • Zinszer K, Morrison K, Verma A, Brownstein JS. Spatial Determinants of Ebola Virus Disease Risk for the West African Epidemic. PLoS Curr Outbreaks 2017 Mar 31;9. pii: ecurrents.outbreaks.b494f2c6a396c72ec24cb4142765bb95. doi: 10.1371/currents.outbreaks.b494f2c6a396c72ec24cb4142765bb95.
  • Zylberman P. Préparation et riposte aux situations d’urgence de portée internationale : un besoin de réformes en profondeur. Dossier : Épidémie d’Ébola : Quels enseignements ? Les prises en charge dans les pays du Nord. adsp mars 2017;98:30-2.




Page lue en 0,0330 seconde (4/0)